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Abstract
The bacterial type VI secretion system is a multicomponent molecular machine directed against
eukaryotic host cells and competing bacteria. It consists of a contractile tubule that is attached
to a membrane protein complex. Upon tubule contraction, a needle is ejected into target cells to
translocate toxic effectors into the cell. Due to structural and functional homologies of several
proteins of the secretion system to proteins of contractile bacteriophage tails, the system is gen-
erally described as an inverted phage tail. Following this analogy, the secretion process is driven
by energy stored in the elongated conformation of the Type VI secretion tubule for which also
partial structural homology to bacteriophage tail sheath proteins has been predicted. However,
this prediction has not been corroborated by structural data so far. The AAA+ ATPase ClpV
plays an important role in the secretion process, as it disassembles the contracted tubule, puta-
tively for recycling of the complex. Even though the binding site for ClpV has been identified in
VipB, the molecular mechanism which recruits the ATPase specifically to the contracted tubule
is not known yet.
In a collaborative project with PD Dr. Axel Mogk and colleagues at the DKFZ Heidelberg
and the group of Dr. Franz Herzog at the Gene Center Munich, we investigate the structure
of the Vibrio cholerae Type VI secretion tubule consisting of the proteins VipA and VipB. We
employ a hybrid methods approach of cryo electron microscopic 3D reconstruction and electron
microscopic and biochemical labeling techniques supported by cross-linking mass spectrome-
try to develop a structural model of VipA and VipB in the tubule. We are able to resolve the
three-dimensional structure of the helical VipA/B tubule up to 6 Å which allows us to locate
secondary structure elements. We describe the arrangement of VipA and VipB in the asym-
metric unit and show that the architecture of the tubule is mainly defined by contacts between
C-terminal domains of VipB which are structurally similar to domain IV of viral tail sheath
proteins. By comparison to the T4 bacteriophage tail sheath, we suggest that these structurally
homologous parts mediate the common function of contraction. Additionally, the VipA/B tubule
has been adapted towards efficient recycling of contracted Type VI secretion systems. VipB is
equipped with a specific four-helix bundle N-terminal domain which carries the ClpV binding
motif. Also for VipA, no correspondency to any other known structural part of a phage-like
contractile system is found. We propose that it serves as a chaperone for VipB. Based on the
observed structural homologies between the T4 phage tail sheath protein and VipB, we model
the elongated state of the VipA/B tubule using known low resolution structures of the elongated
T4 phage tail. Furthermore, we suggest a molecular mechanism for Type VI secretion tubule re-
cycling. In the elongated state of the tubule, the VipB N-terminal domain is hidden in the tubule
wall, making the ClpV binding motif inaccessible for the ATPase. Therefore, ClpV-mediated
recycling of the tubule is restricted to its contracted state.
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Zusammenfassung
Das bakterielle Typ-VI-Sekretionssystem ist eine aus vielen unterschiedlichen Teilen bestehen-
de molekulare Maschine, die gegen eukaryotische Wirtszellen und konkurrierende Bakterien
gerichtet ist. Sie besteht aus einem kontraktionsfähigen Tubulus, welcher mit einem Komplex
aus Membranproteinen verbunden ist. Durch Kontraktion des Tubulus wird eine Nadel in eine
Zielzelle gestoßen, um Gifte in die Zelle zu injizieren. Aufgrund von strukturellen und funktio-
nalen Homologien von einigen Proteinen des Sekretionssystems zu Proteinen des kontraktions-
fähigen Bakteriophagenschwanzes wird das System allgemein als umgedrehter Phagenschwanz
beschrieben. In dieser Analogie wird der Sekretionsprozess durch die in der elongierten Kon-
formation des Typ-VI-Sekretionstubulus gespeicherte Energie angetrieben. Für ihn wurde auch
eine teilweise strukturelle Homologie zum Mantelprotein des Bakteriophagenschwanzes vorher-
gesagt, aber nie durch strukturelle Daten belegt. Die AAA+ ATPase ClpV spielt eine wichtige
Rolle im Sekretionsprozess, da sie den kontrahierten Tubulus zerlegt, vermutlich zur Wieder-
verwertung des Komplexes. Obwohl die ClpV-Bindestelle in VipB bereits identifiziert wurde,
ist der molekulare Mechanismus, der die ATPase ausschließlich an kontrahierten Tubuli binden
lässt, unbekannt.
In einem Kollaborationsprojekt mit PD Dr. Axel Mogk und Mitarbeitern am DKFZ Hei-
delberg und der Gruppe von Dr. Franz Herzog am Gen-Zentrum München, untersuchen wir die
Struktur des Typ-VI-Sekretionstubulus aus Vibrio cholerae, welcher aus den Proteinen VipA und
VipB besteht. Wir verbinden in unserem Ansatz die 3D-Rekonstruktion aus kryo-elektronen-
mikroskopischen Bildern mit elektronenmikroskopischen und biochemischen Markierungsme-
thoden und entwickeln ein Strukturmodell von VipA und VipB im Tubulus, welches durch den
massenspektrometrischen Nachweis chemisch quervernetzter Peptide gestützt wird. Wir können
die dreidimensionale Struktur des helikalen VipA/B-Tubulus bis auf 6 Å auflösen, was es uns er-
möglicht, Sekundärstrukturelemente zu lokalisieren. Wir beschreiben die Anordnung von VipA
und VipB in der asymmetrischen Untereinheit und zeigen, dass die Architektur des Tubulus
hauptsächlich durch Kontakte zwischen C-terminalen Domänen von VipB bestimmt wird, wel-
che strukturell der Domäne IV der Mantelproteine des Bakteriophagenschwanzes ähneln. Der
Vergleich mit dem Mantel des T4 Bakteriophagenschwanzes, führt uns zu dem Vorschlag, dass
diese struktur-homologen Bestandteile die gleiche Funktion in der Kontraktion besitzen. Zusätz-
lich ist der VipA/B-Tubulus einer effizienten Wiederverwertung des Typ-VI-Sekretionssystems
angepasst. VipB besitzt eine spezielle N-terminale Domäne, die aus einem Bündel aus vier He-
lices besteht und das Erkennungsmotiv für ClpV trägt. Für VipA finden wir ebenfalls keine Ent-
sprechung zu anderen phagen-ähnlichen kontraktionsfähigen Systemen. Unserer Ansicht nach
dient es als Chaperon für VipB. Basierend auf den beobachteten Strukturhomologien zwischen
dem Mantelprotein des T4 Bakteriophagenschwanzes und VipB, entwerfen wir unter der Ver-
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wendung von niedrig aufgelösten Strukturen des elongierten T4 Phagenschwanzes ein Modell
des elongierten Zustands des VipA/B-Tubulus. Des Weiteren schlagen wir einen molekularen
Mechanismus für die Wiederverwertung des Typ-VI-Sekretionstubulus vor. Im elongierten Zu-
stand des Tubulus ist die N-terminale Domäne von VipB in der Wand des Tubulus versteckt.
Daher ist das ClpV-Erkennungsmotiv für die ATPase nicht zugänglich und der Abbau des Tubu-
lus durch ClpV auf seinen kontrahierten Zustand beschränkt.
3
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1 Introduction
Bacteria employ a variety of secretion systems to interact with their environment and co-inhab-
iting species. There are seven secretion systems known, with Type I-VI being mainly present
in Gram-negative bacteria, while the Type VII secretion system is only used by Gram-positives
(Fig. 1.1).
The secretion systems in Gram-negative bacteria can be distinguished on whether they de-
pendent on the contact with another cell (Type III-IV), or if they are contact-independent (Type
I-II). The Type I secretion system consists of three components: an ATP binding cassette, a
membrane fusion protein in the inner membrane, and an outer membrane protein. They act
together to transport substrates, that are recognized by a C-terminal signal sequence [Thomas
et al., 2014]. Oppositely, the Type II secretion machinery is rather complex and substrates are
transported via the bacterial SecYEG or Tat pathway into the periplasm, before they enter the
Type II secretion system. The system itself consists of a bell-shaped outer membrane complex
and an inner membrane complex with an associated ATPase [Nivaskumar and Francetic, 2014].
Also, the Type III secretion system is a complex nano-machine employed by pathogenic bacte-
ria to inject effector proteins in an one-step mechanism into eukaryotic cells. It is anchored in
both the outer and the inner membrane and proteins are recognized by a N-terminal signaling
sequence before being transported in an unfolded state driven by an ATPase [Burkinshaw and
Strynadka, 2014, Puhar and Sansonetti, 2014]. In contrast, substrates are not necessarily translo-
cated in an one-step mechanism in the Type IV secretion (T4S) system, as here a small subset
of effectors bear N-terminal Sec signal sequences instead of T4S-specific ones and putatively
enter the Type IV secretion system in the periplasm. It consists of two membrane protein com-
plexes in the inner and outer membrane that are connected by a stalk, and is energized by three
different ATPase complexes [Christie et al., 2014]. The family of Type V secretion systems is
heterogenous. All five subclasses have in common that they rely on the Sec translocon to reach
the periplasm and the Bam complex is involved in the transport across the outer membrane. The
Bam complex helps the proteins to fold into a β barrel shape in the outer membrane. Four of the
five subclasses are otherwise autotransporters except Type Vb, which is a two-partner secretion
system [van Ulsen et al., 2014]. The Type VI secretion (T6S) system was first characterized in
2006 by Pukatzki et al. and Mougous et al.. It consists of a needle complex inside a contractile
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Fig. 1.1: Schematic representation of architecture and function of bacterial secretion sys-
tems I - VII. from left to right: The Type I secretion system consists of an ATP-binding cassette
transporter (ABC), a membrane fusion protein (MFP) and an outer membrane protein (OMP).
The Type III secretion system involves a needle complex inside a basal body anchored in the in-
ner (IM) and outer membrane (OM). Secretion is controlled by an export gate and powered by an
ATPase. In the Type II secretion system, a secretin forms a channel across the outer membrane.
Translocation involves pilins situated upon an inner membrane complex which is connected by
a connecting module (CM) to the secretin. Secretion is energized by an ATPase and is Sec or Tat
pathway dependent. The Type IV secretion system is formed by an inner membrane complex
(IMC), an outer membrane / core complex (OMC) and a pilus secreted from it to the cell exte-
rior. Some Type IV secretion substrates are Sec-dependent. Three ATPases are associated with
the system. Type V secretion system acts via the Sec pathway and an autotransporter activity of
secreted substrates or associated proteins. The Type VI secretion system consists of contractile
tubule holding a needle complex. The tubule is attached to a membrane complex crossing both
membranes and an ATPase is associated to the system. In Typ VII secretion, substrates are trans-
ported across the inner membrane by a membrane complex with ATPase activity. Additionally,
a cytosolic ATPase is involved. The channel across the outer membrane is not known. ATPase
functions are marked in green and secretion pathways are indicated. The main functions of the
secretion system are listed underneath.
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tubule which is attached to a membrane complex. The system has been investigated functionally
and structurally since then. A summary of the current functional and structural data is presented
in the following chapter. For the Type VII secretion system which is employed in Gram-positive
bacteria, it is not clear whether substrates are translocated in a one-step mechanism directly from
the cytoplasm to the cell exterior or if the two membrane are crossed in two steps. Here, secre-
tion is likely energized by an ATPase and substrates are recognized by a helix-turn-helix domain
followed by a YxxxD/E motif. [Houben et al., 2014].
1.1 Distribution and organization of the Type VI secretion
locus
Table 1.1: Tss/Tag nomenclature and corre-
sponding generic names.
Nomenclature Generic Name
TssB VipA
TssC VipB
TssD Hcp
TssH ClpV
TssI VgrG
TagE PpkA
TagF PppA
TagH Fha
T6S systems have been found in a quarter of
all available genomes of gram-negative bac-
teria [Das and Chaudhuri, 2003, Schlieker
et al., 2005, Bingle et al., 2008, Boyer et al.,
2009]. One third of those carry more than one
copy of the T6S locus [Boyer et al., 2009].
T6S loci can be divided into three phyloge-
netically distinct groups present in the Bac-
teroidetes phylum, in Francisella species and
in other Proteobacteria [Bingle et al., 2008,
Boyer et al., 2009, Bröms et al., 2010, Rus-
sell et al., 2014b]. The general proteobacterial
T6S system consists of 13 conserved genes
[Zheng and Leung, 2007, Bingle et al., 2008, Boyer et al., 2009, Zheng et al., 2011, Lin et al.,
2013], which are usually named according to the tss (type six secretion) nomenclature tss(A-M),
and a subset of tss-associated genes tag(A-P) [Shalom et al., 2007]. However, some parts of the
secretion system are referred to by their generic names in the literature and also in this work (see
table 1.1). Bioinformatic analysis separates the 13 core genes into two clusters which encode es-
sential proteins that form a membrane complex and a phage-related complex (Fig. 1.2). [Boyer
et al., 2009, Zoued et al., 2014].
The membrane complex cluster consists of the genes tssJ, tssK, tssL and tssM. TssL and
TssM are homologues of inner membrane proteins DotU and IcmF of the Legionella Type IV
secretion system, whereas TssK is a cytoplasmic protein that interacts with members of the
membrane and the phage-related complex [Zoued et al., 2013]. TssJ is located in the outer
membrane [Felisberto-Rodrigues et al., 2011]. The remaining genes form the phage-related
7
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Fig. 1.2: The T6S locus. The 13 T6S core genes can be functionally divided into a membrane
(left) and a phage-related complex (right). The localization of the encoded proteins in the T6S
membrane or phage-related complex is indicated; IM: inner bacterial membrane, OM: outer
bacterial membrane. Genes in white color-code have not been functionally characterized yet.
The genes are represented according to the consensual genomic organization of the locus as
defined by Boyer et al. [2009]. Genes which have a conserved relative transcriptional orientation
are connected. The thickness of the connecting line corresponds to the indicated conservation
frequency in per cent. The figure has been partially adopted from Boyer et al. [2009].
complex based on homologies of VipB to bacteriophage tail sheath proteins [Lossi et al., 2013],
of Hcp to phage tail tube proteins gp19 of T4 phage [Leiman et al., 2009] and gpVN of λ phage
[Pell et al., 2009], of VgrG to the T4 baseplate/tail spike proteins gp27-gp5 [Leiman et al., 2009],
and of TssE to T4 baseplate wedge protein gp25 [Leiman et al., 2009, Lossi et al., 2011]. The
class II AAA+ ATPase ClpV is not related to phage proteins but is functionally connected to the
complex [Schlieker et al., 2005, Bönemann et al., 2009, Basler et al., 2012] and no functional
data is available for TssA, TssF and TssG apart from being essential for the system [Zheng and
Leung, 2007, Boyer et al., 2009, Zheng et al., 2011, Lin et al., 2013].
The Francisella Type VI secretion system (T6SII) encoded in the Francisella pathogenecity
island is clearly distinct from the general proteobacterial Type VI secretion system (T6SI) [Bin-
gle et al., 2008, Bröms et al., 2010]. It contains homologues for VipA (IglA), VipB (IglB), Hcp
(IglC), VgrG, TssA, TssK, TssF , TssL (DotU) and TssM (IcmF/PdpB) [Bingle et al., 2008,
Boyer et al., 2009, Bröms et al., 2010, de Bruin et al., 2011, Russell et al., 2014b]. However,
IglF, which has been proposed to take over the role of the AAA+ ATPase ClpV, lacks Walker A
and B motifs, and Francisella VgrG comprises only the very C-terminus of the gp27-like part
(phage baseplate) but the whole gp5-like (phage tail spike) part of regular VgrG proteins [Barker
et al., 2009, Bröms et al., 2010]. Recently, a T6S system has been found in the Bacteroidetes
phylum which also forms its own phylogenetic group (T6SIII). Here, homologues for TssA,
TssJ, TssM and TssL have not been found which comprises almost the complete membrane
complex of the secretion system [Russell et al., 2014b].
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1.2 Structural biology of the T6S system
As described before, the T6S apparatus can be divided into a membrane complex part (Fig.
1.3) and a phage-like tubulus [Zoued et al., 2014]. The available structural and functional data
suggests that the secretion system resembles an inverted phage tail which is integrated into the
outer and the inner bacterial membrane.
1.2.1 The membrane complex
Fig. 1.3: Available structural data of the T6S membrane complex. The membrane complex
consists of the proteins TssJ, TssK, TssL and TssM. The lipoprotein TssJ has been crystallized
(3RX9). It is anchored in the outer membrane (OM) and interacts with TssM via a N-terminal
loop (green). TssK is a trimeric cytoplasmic protein (EMD-5739) which interacts with the mem-
brane complex as well as with the phage-like complex. The cytoplasmic domain of TssL (3U66)
is anchored via a C-terminal transmembrane domain which is extended in some cases with a
periplasmic peptidoglycan binding motif. It is suggested that protein TagL acts as an adaptor to
the peptidoglycan layer when this binding motif is not present in TssL. Periplasmic protein TssM
interacts with TssJ and is anchored with three transmembrane helices into the inner membrane
(IM). It carries a Walker A and a Walker B motif in the loop region between transmembrane
helix 2 and 3.
The T6S locus encodes for three membrane proteins, TssJ, TssL and TssM. TssJ is a
lipoprotein with a transthyretin fold located in the outer membrane and extends into the periplasm
[Aschtgen et al., 2008, Felisberto-Rodrigues et al., 2011, Rao et al., 2011, Robb et al., 2013].
It oligomerizes in vivo [Rao et al., 2011]. Furthermore it interacts with the periplasmic do-
main of TssM in an 1:1 ratio via a N-terminal loop region [Felisberto-Rodrigues et al., 2011].
TssM itself is located in the inner membrane, with three N-terminal transmembrane helices and
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a big C-terminal periplasmic domain which self-interact in yeast-two-hybrid studies [Ma et al.,
2009b]. The Agrobacterium tumefaciens TssM contains Walker A and B motifs in between the
second and the third transmembrane helix [Ma et al., 2009b, 2012]. The motifs are essential for
T6S activity in A. tumefaciens, but not in Edwardsiella tarda [Zheng and Leung, 2007]. TssM
forms a complex with TssL in the membrane [Ma et al., 2009b], which itself is not stable with-
out its binding partner [Bröms et al., 2012]. TssL is anchored with a C-terminal transmembrane
helix in the membrane, the N-terminal part faces the cytoplasm [Aschtgen et al., 2012]. In A.
tumefaciens the C-terminus is extended by an OmpA peptidoglycan-binding motif [Ma et al.,
2009b], while in enteroaggregative Escherichia coli (EAEC) TssL, such a domain is missing
[Durand et al., 2012b]. However, it is suggested that this function is taken over by an adaptor
protein called TagL [Aschtgen et al., 2010a,b]. TssL transmembrane helices mediate dimeriza-
tion of the protein [Durand et al., 2012b]. The cytoplasmic domain consists of two three-helix
bundles that are arranged in a hook-like shape [Durand et al., 2012b, Robb et al., 2012]. Nega-
tively charged residues are situated in the cleft of the hook, which are essential for T6S function
in F. tularensis [Bröms et al., 2012]. Due to the oligomerization properties of all the membrane
proteins TssJ, TssL and TssM, it is hypothesized, that they form a channel-like structure across
both membranes [Zoued et al., 2014]. The membrane and the phage-related complex is pro-
posed to be connected by the cytoplasmic protein TssK [Zoued et al., 2013]. It forms trimers
and interacts with the cytoplasmic part of TssM and TssL as well as with TssA, VipA/B and
Hcp.
1.2.2 The phage-like complex
The phage-like complex consists of a hollow needle formed by Hcp, which is surrounded by a
contractile sheath consisting of VipA and VipB and which is spearheaded by VgrG and a PAAR
repeat protein (Fig. 1.4). A baseplate complex composed of TssE and VgrG is attached to
the membrane complex [Zoued et al., 2014]. Hcp oligomerizes into hexameric rings of 85 Å
diameter in vitro forming a 24-stranded β-barrel on the inside. It is structurally homologous
to the tail tube protein of λ phage and T4 phage [Mougous et al., 2006, Leiman et al., 2009,
Pell et al., 2009]. P. aeruginosa Hcp3 hexamers form tubules in vitro and it has been shown
that EAEC Hcp1 rings assemble in a head-to-tail fashion in vivo [Leiman et al., 2009, Brunet
et al., 2014, Douzi et al., 2014]. However, binding between Hcp rings is weak, the kD was
measured to be approximately 7 µM [Douzi et al., 2014]. Hcp directly interacts with VgrG-1 in
A. tumefaciens [Lin et al., 2013].
A VgrG trimer forms the tail spike. The N-terminal fragment (1-483 aa) of E. coli c3393
VgrG has been crystallized [Leiman et al., 2009]. The first 370 residues are structurally ho-
mologous to T4 baseplate protein gp27. They fold into four domains of which the first and
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Fig. 1.4: Available structural data of the T6S phage-like complex. The phage-like complex
consists of the proteins VipA, VipB, Hcp, VgrG and TssE and putatively also TssA, TssF and
TssG. For VipA no structural data is available, but it is predicted that the C-terminal region of
VipB is structurally homologous to viral tail sheath proteins, e. g. DSY3957 (3HXL). Hcp
(1Y12) is structurally homologous to viral tail tube proteins and forms hexameric rings. The
tip of the tube is formed by VgrG which is structurally homologous to proteins forming the
baseplate and the tail tip in bacteriophages. Crystal structures of the N-terminal five domains
(2P5Z) and a C-terminal β helical fragment (3WIT) have been solved. The tip is sharpened by
a PAAR repeat containing protein (4JIW). TssE is structurally homologous to the tail sheath
initiator proteins gp25 (2IA7).
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the third one are seven-stranded β barrels that assemble into a pseudohexamer in the VgrG
trimer. Thereby, they serve as an adapter between the hexameric Hcp ring and the trimeric
spike complex. The other two domains connect the adapter to a fifth domain that resembles the
oligosaccharide/oligonucleotide-binding (OB)-fold domain of T4 gp5 tail spike protein. How-
ever, a lysozyme domain, which directly follows the OB-fold domain in the T4 gp5 protein, is
missing in VgrG. The remaining C-terminal part of VgrG trimerizes into a β helical structure
with a triangular outline which is capped and sharpened by a PAAR repeat protein with a coor-
dinated zinc ion resembling VCA0105 in Vibrio cholerae [Leiman et al., 2009, Shneider et al.,
2013, Uchida et al., 2014]. Another protein with homologies to the bacteriophage baseplate is
the gp25-like protein TssE [Leiman et al., 2009]. According to structure predictions, it consists
of a 3-stranded anti-parallel β sheet with three N-terminal α helices wrapped around it on one
side. A conserved glutamate situated in a loop between the third α helix and the first β strand is
essential for T6S [Lossi et al., 2011].
In contractile bacteriophages, the needle complex is surrounded by a contractile sheath.
This role is taken over by the contractile VipA/B tubule in the T6S system. VipA and VipB
stabilize each other and form large tubular complexes [Bönemann et al., 2009, Bröms et al.,
2009, Lin et al., 2013]. Heterologously expressed, the tubules are 300 Å wide and have a 12-
meric cog-wheel outline when seen from top [Bönemann et al., 2009]. For a homologue in P.
aeruginosa, also 13-meric top views have been observed [Lossi et al., 2013]. In vivo, the VipA/B
tubules exist in two conformations, an elongated one with a diameter of 240 Å and a contracted
one with right-handed helical ridges (according to a tomogram average) and a diameter similar
to the heterologously expressed T6S tubules [Basler et al., 2012]. The findings are reminiscent
of the contractile tail of the bacteriophage and indeed, the C-terminal 150 aa of VipB are weakly
homologous to the C-terminus of T4 tail sheath protein gp18 [Lossi et al., 2013]. The VipB C-
terminal region is also essential for tubule formation but not necessary for interaction with VipA
[Aubert et al., 2010]. This interaction is mediated by a long α helix in the C-terminal half of
VipA which carries a hydrophobic motif resembling a leucin-zipper [Bröms et al., 2009, Zhang
et al., 2013].
V. cholerae VipB has a specific binding motif LLDEIM for the AAA+ ATPase ClpV on an
α helix at its N-terminus [Kapitein et al., 2013]. ClpV binds to the motif with its specifically
adapted N-terminal domain which carries an additional α0 helix compared to other Hsp100
ATPases. Helices α0 and α1 form a hydrophobic groove into which the N-terminal LLDEIM
motif carrying VipB α helix binds. However, in the P. aeruginosa H1-T6S system and others,
neither the ClpV binding motif is present on VipB nor the hydrophobic groove in the N-terminal
domain of ClpV. In these cases, recruitment of ClpV to the tubule is suggested to be mediated
by TagJ which binds to the VipA N-terminus [Forster et al., 2014].
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1.3 Related phage tail-like structures
Apart from the T6S system and contractile bacteriophages, other phage tail-like structure have
been identified in prokaryotes: R-type pyocins, rhapidosomes, the Photorhabdus luminescens
virulence cassette, the Serratia entomophila anti-feeding prophage, the metamorphosis-associated
contractile structure (MAC) of Pseudoalteromonas luteoviolacea. The latter three are combined
phylogenetically in the PLTS (phage-like protein translocation structure) cluster [Sarris et al.,
2014].
1.3.1 The minimal contractile bacteriophage tail
Fig. 1.5: The minimal contractile bacteriophage tail according to Leiman and Shneider
[2012]. Proteins gp5 and gp27 form the baseplate hub (green) around which the other baseplate
proteins (orange) gp6, gp53/gp7 and gp25 assemble. Tail fibers (brown) are attached to the
baseplate. The tail tube (gp19, yellow) assembly is initiated by gp48/gp54 (blue). A tail sheath
consisting of gp18 proteins (light blue) wraps around it. Assembly of the tube and the sheath is
terminated by gp3 (dark yellow) and gp15 (dark blue), respectively.
Leiman and Shneider [2012] describe a theoretical minimal bacteriophage tail structure
(Fig. 1.5). Gp27 and gp5 trimers form a hub-like structure. The gp27 trimer has a donut-like
shape with pseudo-hexameric symmetry into which the gp5 trimer is inserted as the needle spike.
The hub is surrounded by gp6, gp25 and gp53. Since the structure of gp25 is similar to domain
IV of tail sheath protein gp18, it is suggested, that they interact, and that gp25 might even serve as
a primer for tail sheath assembly. A hexamer of gp25 surrounds the hub, followed in concentric
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Fig. 1.6: Gp18 fold with three insertion domains. left: gp18 structure 3J2N; domain I is
colored in green, domain II in orange, domain III in light blue and domain IV in blue. right:
schematic representation of gp18 fold adapted from Leiman and Shneider [2012].
hexagonal layers by six gp6 dimers and six proteins orthologous to gp53/gp7. The tail fibers are
attached to the baseplate. For polymerization of the tube, a tail tube initiator complex consisting
of proteins gp48 and gp54 forms upon the gp27 trimer. A tape measure protein with an elongated
α helical conformation extends from the initiator complex and determines the length of the tail.
The tail tube is formed by hexameric gp19 rings and the tail sheath wraps in six right-handed
helical protofilaments around it. All viral tail sheath proteins have a similar fold. They consist
of up to four domains. Domain IV is formed by the C-terminal 120 to 150 aa and the N-terminal
20 to 30 aa. Domain III is inserted into domain IV, domain II into III and I into II (Fig. 1.6)
[Aksyuk et al., 2011]. Tail tube and sheath are capped by the terminator complex consisting of
tube terminator protein gp3 and sheath terminator protein gp15.
1.3.2 R-type pyocins
R-type pyocins resemble head-less contractile bacteriophages [Ishii et al., 1965, Michel-Briand
and Baysse, 2002, Leiman and Shneider, 2012], do not contain DNA [Ishii et al., 1965, Michel-
Briand and Baysse, 2002, Leiman and Shneider, 2012], and are related to P2 phage tails [Nakayama
et al., 2000]. They possess just one tail sheath protein with around 40 kDa molecular weight
[Nakayama et al., 2000, Gebhart et al., 2012]. The pyocin gene cluster is present in the genomes
of P. aeruginosa and other gram-negatives and also gram-positive bacteria and expression is
activated via RecA upon DNA damage [Matsui et al., 1993, Williams et al., 2008, Leiman and
Shneider, 2012]. Once expression of pyocin genes is induced, one bacterial cell produces up to
200 pyocin particles, which are released by lysis [Scholl et al., 2009]. The target of the released
pyocin are determined by their tail fibers as it is the case in bacteriophages [Williams et al., 2008,
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Scholl et al., 2009]. When attached to the membrane of their bacterial target, they contract and
kill the cell by membrane depolarization [Uratani and Hoshino, 1984]. Pyocins are highly potent
toxins as one pyocin particle is sufficient to kill a bacterium. Usually, the P. aeruginosa strain
that carries the pyocin genes, is resistant to its own toxins [Leiman and Shneider, 2012].
1.3.3 Rhapidosomes
Rhapidosomes have been first described by Lewin [1963] as rod-shaped ribonucleoprotein par-
ticles reminiscent of bacteriophage tails in Saprospira grandis. They appear in two kinds, as
hollow cylinders or cylinders of a similar diameter filled with a smaller cylindrical core. Later
rhapidosomes haven been found in Photobacterium, Proteus and Pseudomonas, whereas for
some rhapidosomes in Saprospira and Pseudomonas, a “brush-like end” was observed, that
might represent a baseplate complex with tail fibers [Yamamoto, 1967]. For P. fluorescens,
appearance of rhapidosomes coincided with R-type pyocin production, and those structures co-
agglutinated with the pyocin when treated with antiserum. This lead to the conclusion that they
represent in fact polysheath structures from pyocin tail sheath protein [Amako et al., 1970]. A
more in-depth analysis of rhapidosomes in Aquaspirillum itersonii showed that they are formed
by at least two proteins of 53 kDa and 29 kDa molecular weight with an additional protein of
18 kDa that co-purified depending on the lysis method [Pazirandeh and Campbell, 1993, Böne-
mann et al., 2010]. However, the diameter of these rhapidosomes of 170 Å is smaller than the
diameter of those described earlier which ranged between 200 and 330 Å [Lewin, 1963, Ya-
mamoto, 1967]. Hence, the term “rhapidosome” might describe a variety of different phage
tail-like structures with different function and origin [Leiman and Shneider, 2012].
1.3.4 Phage-like protein translocation structures
Other phage-like structures related to the P2 phage tail are summarized in the PLTS cluster
[Sarris et al., 2014]. The anti-feeding prophage (Afp) in Serratia entomophila and its homologue
in the Photorhabdus virulence cassette (PVC) are both pyocin-like toxins which are secreted and
directed against insects [Rodou et al., 2010, Leiman and Shneider, 2012]. PVC leads to actin
cytoskeleton rearrangements in insect and mammalian haemocytes, while to date Afp only acts
on the New Zealand grass grub Costelytra zealandica leading to cessation of feeding in larvae
[Yang et al., 2006, Hurst et al., 2007]. The gene cluster encode for three tail sheath orthologues
with sizes between 40 and 50 kDa, two Hcp orthologues, and orthologues to baseplate proteins,
an AAA+ ATPase and a terminator protein [Hurst et al., 2004, Yang et al., 2006, Hurst et al.,
2007].
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The S. entomophila anti-feeding prophage has been characterized biochemically and elec-
tron microscopically. The AAA+ ATPase is absolutely necessary for any Afp particle formation,
while in the absence of the terminator protein only the baseplate and the tail tube of the particle
but no sheath is formed. Furthermore, C-terminal truncation of the terminator protein leads to
aberrant tail sheath formation. Finally, the tail sheath contains stoichiometric amounts of two
major tail sheath proteins and a third protein in a smaller amount [Rybakova et al., 2013]. The
tail sheath shows six-fold rotational symmetry, a unit rise of 8.14 nm and a unit twist of 40.5 °
in a low-resolution cryo EM reconstruction of the elongated Afp particle. When the needle is
segmented from the EM density, it demonstrates a unit rise of 4.06 nm and a unit twist of 20.1 °.
The isolated needle density can accommodate Hcp rings. Interestingly, a combination of two tail
sheath proteins fit into a segmented sheath subunit, even though all of them show approximately
~40 % sequence similarity in the C-terminal regions to T4 tail sheath protein gp18 [Heymann
et al., 2013].
The recently described metamorphosis-associated contractile structures (MACs) in Pseu-
doalteromonas luteoviolacea possess just one tail sheath protein of around 62 kDa [Shikuma
et al., 2014]. They also resemble pyocins and are released by cell lysis, but in contrast, they
form huge hexameric arrays in the cell by connecting with their tail fibers. MACs can induce
metamorphosis in marine tube worms by an unknown mechanism.
1.4 T6S effectors
Bacteria can deploy effector proteins directed against bacteria or eukaryots, or in some cases
both, via their T6S system. The majority of characterized effectors targets bacteria, only a few
types of anti-eukaryotic effectors have been described so far. However, many pathogens are
known to mediate virulence against their host by their T6S systems [Coulthurst, 2013]. There
is no general signal sequence known, that determines whether an effector is translocated via the
T6S, but PAAR repeats and and conserved residue pattern at the N- or C-termini of effectors have
been connected to T6S translocation [Shneider et al., 2013, Salomon et al., 2014]. T6S effectors
and their use in interbacterial or pathogen-host interactions have been reviewed recently [Durand
et al., 2014, Russell et al., 2014a].
Certain VgrG proteins carry C-terminal toxin domains, such as the VgrG1 protein of V.
cholerae which carries a C-terminal domain homologous to the actin cross-linking domain
(ACD) of the V. cholerae toxin RtxA and cross-links actin in vivo after endocytosis of V. cholerae
cells [Pukatzki et al., 2007, Ma et al., 2009a]. The ACD is connected to the VgrG1 via a 100 aa
disordered linker and cross-links G-actin in the presence of ATP and magnesium ions [Durand
et al., 2012a]. By reducing the amount of G-actin in the cell, less bacteria can be phagocy-
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tosed by macrophages, until phagocytosis is completely inhibited. As a consequence, with the
sacrifice of few bacterial cells, the main V. cholerae population is saved from the phagocytic
cell [Satchell, 2009]. An Aeromonas hydrophila CTD of VgrG1 also interferes with the actin
cytoskeleton. The CTD is a vegetative insecticidal protein (VIP-2) domain that causes ADP-
ribosylation of actin. HeLa cells cultivated in direct contact with A. hydrophila with a func-
tional T6S show cell rounding and ectopic expression of VgrG1 in those cells causes apoptosis
[Suarez et al., 2010]. V. cholerae VasX is an VgrG-independent effector with anti-eukaryotic
activity and putatively secreted directly via the Hcp needle. It possibly targets phosphaditylinos-
itol phosphate-dependent pathways as it contains a N-terminal pleckstrin homology domain and
interacts with acidic phospholipids and phosphaditylinositol phosphates [Miyata et al., 2011].
Furthermore, it is also an antibacterial toxin, which forms pores in the inner membrane when
present in the periplasm [Zheng et al., 2011, Miyata et al., 2013b]. Other bifunctional T6S tox-
ins are PldA and PldB of Pseudomonas aeruginosa with phospholipase D (pld) activity [Russell
et al., 2013, Jiang et al., 2014]. PldA is delivered by the H3-T6S and PldB by the H2-T6S sys-
tem of P. aeruginosa, both attack the inner bacterial membrane from the periplasmic side by
hydrolyzing phospholipids into the head group and phosphatidic acid. However, PldA and PldB
are also promoting bacterial invasion of eukaryotic cells by activation of the PI3K/Akt pathway
without being cytotoxic themselves [Jiang et al., 2014].
Antibacterial T6S effectors are far better characterized. Generally they are distinguished
by their known target, which is to date the cell wall, the membrane or the DNA, and their
enzymatic activity. In the bacterial genome, they are generally bicistronically encoded as toxin-
antitoxin pairs to protect bacteria from their own effectors [Russell et al., 2011, Durand et al.,
2014]. However, orphan antitoxin (immunity) proteins are often retained in the bacterial genome
[Russell et al., 2012]. The first antibacterial effectors have been identified in P. aeruginosa as
either muramidases/glycoside hydrolases (Tge1PA) and or amidases (Tae1PA) that degrade the
periplasmic murein layer [Hood et al., 2010, Russell et al., 2011, Whitney et al., 2013]. In this
case, the corresponding immunity proteins do not protect the cell from the produced toxins, but
from T6S attacks of their own species, as Tge1PA and Tae1PA are directly exported from the
cytoplasm of the attacker into the target periplasm [Russell et al., 2011]. Tge family enzymes
can be divided into three, the Tae family into four phylogenetic clades with differing enzymatic
activity [Russell et al., 2012, Whitney et al., 2013]. Also CTDs of VgrG proteins can possess
peptidoglycan hydrolysis activity. VgrG3 of V. cholerae is equipped with a chitosanase CTD and
additionally with a peptidoglycan binding domain which putatively retains the protein attached
to the murein layer [Brooks et al., 2013, Dong et al., 2013, Jiang et al., 2014].
Complementary to effectors attacking the murein layer, there are also enzymes targeting
the bacterial membrane translocated by the T6S system. They form five phylogenetic clades, of
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which the first four (Tle1-4) possess a GXSXG motif common for lipases and esterases and the
fifth one (Tle5) a dual HxKxxxxD motif typical for phospholipase D enzymes [Russell et al.,
2013]. Some of them do not only target the inner bacterial membrane but also act as anti-
eukaryotic effectors (see above). This is also the case for VasX, which is predicted to resemble
pore-forming colicin and causes leakage of the inner membrane when artificially targeted to the
periplasm of VasX-producing cells [Miyata et al., 2013b].
Apart from those described before, there are also T6S effectors which are active in the
cytoplasm [Hood et al., 2010, Fritsch et al., 2013]. Two Type VI effectors RhsA and RhsB in
Dickeya dadanti target bacterial DNA with their C-terminal nuclease domains [Koskiniemi et al.,
2013]. They also contain rearrangement hot-spot/tyr-asp (Rhs/YD) repeats that are associated
with other toxic effectors such as the ABC toxin complexes where they are proposed to act as
a protective capsule for an unfolded cytotoxic effector domain [Busby et al., 2013]. Further-
more, the Tde effector family in A. tumefaciens possesses DNase activity in vivo, that confers an
intra- and interspecies competitive advantage in plant colonization [Ma et al., 2014]. Nuclease
domains are also predicted in other T6S effectors [Salomon et al., 2014, Whitney et al., 2014].
1.5 Regulation of T6S expression
Bacteria often tightly control the expression of T6S genes depending on e. g. quorum sens-
ing [Ishikawa et al., 2009], biofilm formation [Aubert et al., 2008], iron [Brunet et al., 2011],
temperature [Pieper et al., 2009, Zhang et al., 2011], osmolarity and salinity [Ishikawa et al.,
2012], and pH [Chakraborty et al., 2010]. A more comprehensive list can be found in Miyata
et al. [2013a]. Two of the more prominent pathways regulating T6S expression are described
in detail: the activation of alternative transcriptional initiator σv54 /RpoN by VasH in V. cholerae
and the Gac/Rsm pathway in P. aeruginosa [Silverman et al., 2012].
VasH is encoded by the T6S cluster in V. cholerae and essential for T6S mediated killing
of amoebae ([Pukatzki et al., 2006] and bacterial cells [Zheng et al., 2011]. Furthermore, trans-
poson insertion in the rpoN locus attenuates virulence against amoebae [Pukatzki et al., 2006].
RpoN binds together with VasH to T6S promotor sequences and is required for transcription.
Additionally, VasH shows auto-phosphorylation in vitro which is indicative for phosphorylation
by sensor kinases in vivo [Bernard et al., 2011]. To act as a bacterial enhancer binding pro-
tein, VasH must hydrolyze ATP to remodel the RNA-Polymerase-RpoN holoenzyme [Bush and
Dixon, 2012]. Kitaoka et al. [2011] showed that both Walker A and B motifs, and a C-terminal
DNA-binding helix-turn-helix domain of VasH is needed for transcriptional activation. How-
ever, there is a discrepancy, whether VasH controls the large T6S cluster and the smaller hcp
operons [Bernard et al., 2011] or only the latter ones [Dong and Mekalanos, 2012].
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In P. aeruginosaΔretS strain expression of T6S cluster HSI-1 is activated [Mougous et al.,
2006]. RetS inhibits auto-phosphorylation of GacS in the GacS/GacA two-component system
[Goodman et al., 2004, 2009, Silverman et al., 2012]. GacA activates expression of sRNA RsmZ
that sequesters the protein RsmA, which otherwise would inhibit translation of T6S transcripts
[Ventre et al., 2006, Lapouge et al., 2008, Silverman et al., 2012].
Considering the expression of the T6S system, there are bacteria with a constitutive active
expression of T6S genes such as V. cholerae strain V52 while others such as P. aeruginosa tightly
regulate the system and signaling pathways have to be impaired to get T6S protein expression
in the lab. It is postulated, that bacteria with a constitutively expressed T6S have evolved to
employ the system mainly in inter-bacterial interactions while a regulation of T6S is needed
when interacting inside a host with eukaryotic cells [Miyata et al., 2013a].
1.6 The secretion process
Based on the model of the inverted phage tail and time-lapse fluorescence microscopy of tagged
T6S complexes in vivo [Basler and Mekalanos, 2012, Basler et al., 2012, Brunet et al., 2013,
Kapitein et al., 2013], the T6S secretion process is generally described as a cycle of secretion
apparatus assembly, rapid contraction and effector translocation, and at least partial secretion
apparatus disassembly (Fig. 1.7).
1.6.1 Tubule assembly
The elongated T6S tubule with the needle complex is attached to a baseplate complex which is
located in the membrane. Whether this baseplate exists preformed in the membrane or assembles
together with the tubule complex, as well as the signal, which leads to its formation, is not
known.
However, a post-translational control mechanism for site-specific T6SS assembly and con-
traction is proposed for P. aeruginosa [Ho et al., 2014]. Here, T6SS formation and activity is
dependent on phosphorylation of protein Fha1 (forkhead-associated 1) at Thr-362 by the ser-
ine/threonine kinase PpkA. De-phosphorylation by the antagonist phosphatase PppA inhibits
T6SS activity [Mougous et al., 2007]. Deletion of Fha inhibits T6SS tubule formation [Kapitein
et al., 2013]. PpkA is a membrane-spanning kinase located in the inner membrane which be-
comes active after auto-phosphorylation and dimerization. Its activity is dependent on the pres-
ence of the periplasmic protein TagR and outer membrane lipoprotein TagQ, to which TagR
is associated [Hsu et al., 2009, Silverman et al., 2011, Casabona et al., 2013]. Additionally, a
complex in the inner membrane reminiscent of bacterial ABC transporters consisting of trans-
membrane protein TagS and the ATPase TagT is needed for PpkA activation [Casabona et al.,
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2013]. “T6S dueling” has been observed in P. aeruginosa, in which cells, that have been at-
tacked by another cell with a T6S system, retaliate with their own T6S system in the precise
direction of the attack in solid culture [Basler and Mekalanos, 2012]. It is therefore proposed
that this temporal and spatial sensing of an assault is conferred by a TagQRST-PpkA/PppA-Fha1
signaling cascade, as co-cultivated V. cholerae and A. baylyi with an active T6S system are at-
tacked by P. aeruginosa dependent on the expression of TagT [Basler et al., 2013]. How the
attack is actually integrated into the system is not known, but the P. aeruginosa T6S system is
also activated TagT-dependently upon E. coli Type IV secretion system mediated conjugation
independent of actual gene transfer and by the presence of membrane-disrupting polymyxin B
[Ho et al., 2013]. This points towards a disruption of the outer membrane as the initial signal that
activates the phosphorylation cascade. In Serratia marcescens, the T6S system is also regulated
via PpkA/PppA-Fha, but proteins TagQRST are not part of its secretion system which is also the
case for many other species [Fritsch et al., 2013]. Furthermore, the T6S system is activated via
this pathway in planktonic growth, as a consequence, T6S activation is also independent from
cell contacts. Hence, also other signals than membrane rupture seem to be integrated over the
PpkA/PppA-Fha cascade (Fig. 1.7 a).
Interestingly, PpkA also directly phosphorylates baseplate complex protein TssL which
greatly increases T6S activity in A. tumefaciens. Afterwards, Fha binds to the phosphorylated
protein, a conformational change is induced in the interacting baseplate complex protein TssM
and Hcp recruitment to TssL is greatly enhanced [Lin et al., 2014]. ATP binding to TssM induces
a conformational switch and its ATPase activity leads to TssM-TssL-Hcp complex formation
[Ma et al., 2009b, 2012]. However, in E. tarda, binding of ATP by TssM is not essential for T6S
activity [Zheng and Leung, 2007].
The baseplate/tube tip proteins VgrG and VCA0105, need to be present for T6S secre-
tion, presumably as a starting point for the T6S assembly (Fig. 1.7 b) [Shneider et al., 2013,
Brunet et al., 2014]. Additionally, Hcp is needed for a proper assembly of VipA and VipB in
the elongated form of the T6S tubule [Kapitein et al., 2013, Brunet et al., 2014]. Furthermore,
gp25 homologue TssE might be necessary as a primer as it has been discussed for the phage tail
[Leiman and Shneider, 2012]. Hcp hexamers form stacks in a head-to-tail fashion and impair-
ment of stack formation inhibits also VipA/B tubule formation [Brunet et al., 2014]. VipA and
VipB cannot be stably expressed on their own or when VipA/B binding is impaired, so it is rea-
sonable to assume that the two proteins are incorporated into the tubule as a dimer [Bönemann
et al., 2009, Bröms et al., 2009, Aubert et al., 2010]. It is proposed that the needle serves as a
template for proper assembly of the T6S sheath. Additionally, the loaded complex is most likely
formed in a coordinated fashion in which Hcp hexamers are included into the complex shortly
before VipA/B protomers are recruited to the same layer of the growing complex (Fig. 1.7 c,
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d) [Zoued et al., 2014]. This is supported by the observation by cryo ET of a putative assembly
intermediate of a short loaded T6SS complex [Chang et al., 2014]. T6S tubule assembly is fast,
Basler et al. [2012] measured 20 - 30 s µm−1 in time lapse fluorescence microscopy recordings.
The length of bacteriophage tails is controlled by tape measure proteins [Davidson et al., 2012],
but a homologue in the T6S system is not known. Also, observations of T6S systems in situ do
not argue for a length control as the contractile tubule can span the whole cell diameter [Basler
et al., 2012, Kapitein et al., 2013]. The postulation, that T6S needs a tail termination protein like
bacteriophages [Zoued et al., 2014], might not be necessary if one assumes a wave-like contrac-
tion mechanism in which the contraction moves processively from the cell membrane to the end
of the T6S tubule as it is suggested for the T4 phage tail [Leiman et al., 2010].
1.6.2 Contraction and effector translocation
In analogy to Myoviridae, the contraction of the T6S tubule is thought to be triggered by a
conformational change in the baseplate complex which is also the end point of the described
signaling pathway [Leiman et al., 2010, Zoued et al., 2014]. Subsequently, the tubule contracts
within at least 5 ms, thereby reducing its length by 45 % and extending its diameter from ap-
proximately 240 Å to 300 Å [Basler et al., 2012]. The conserved domains IV and III of viral
tail sheath proteins are mainly involved in the contraction process [Aksyuk et al., 2009, Leiman
et al., 2010]. Since the VipB C-terminus is predicted to share structural homology with domain
IV, it is likely that the contraction of the T6S tubulus resembles that of the bacteriophage tail
[Aksyuk and Rossmann, 2011, Lossi et al., 2013]. Here, the contraction process can be de-
scribed as rigid-body movements of the individual subunits [Aksyuk et al., 2009, Leiman and
Shneider, 2012]. However, so far only low resolution structures are available for elongated
and contracted phage tails, which makes it difficult to judge whether this postulation holds true
[Leiman et al., 2004, Kostyuchenko et al., 2005, Aksyuk et al., 2009, 2011, Effantin et al., 2013,
Leiman and Shneider, 2012].
During T4 phage tail contraction, the subunits of one disc of the tubule move radially out-
wards and rotate approximately 45 ° clockwise in a trajectory parallel to the baseplate. By this
movement, the subunits of a subsequent disc get inserted in between the subunits of the first one
which widens the inner diameter of the tail sheath. Domain IV of gp18 maintains connectivity
in the protofilament during contraction, while the other domains form new contacts increasing
the contact area four-fold. The additional contacts provide the enthalpy gain which drives the
contraction movement [Aksyuk et al., 2009]. However, there is indirect evidence from spec-
troscopic data, that the tail sheath secondary structure content changes during contraction of
the T4 tail and also of the P. aeruginosa R1 pyocin [Venyaminov et al., 1975, Uratani, 1982].
Furthermore, protomers in a protofilament in the viral contractile tail sheath might be linked by
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Fig. 1.7: Model for the T6S secretion process. (a) Activation of PpkA/PppA-Fha signaling
cascade leads to phosphorylation of TssL and binding of Fha. (b) This activates ATP hydrolysis
in TssM thereby inducing a conformational change and recruitment of VgrG/VCA0105 as well
as Hcp to the baseplate complex. (c) Needle and VipA/B tubule are assembled in a coordinated
manner. (d) The loaded complex is ready to contract. (e) Contraction of the VipA/B tubule
leads to ejection of the needle complex. (f) The contracted VipA/B tubule is disassembled by
the AAA+ ATPase ClpV.
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so called “chain-swapping” in the C-terminal domains of gp18-like proteins as it is observed in
a crystal of gp18-like protein DSY3957 (3HXL) [Aksyuk et al., 2011, Leiman and Shneider,
2012]. Here, the N-terminus forms a β sheet with the C-terminal β strands in domain IV of a
neighboring DSY3957 protein. By linking the protomers, the contractile machine should gain
more stability. Due to the predicted structural homology of domain IV to the VipB-C domain, a
similar mechanism has also been suggested for the T6S system [Zoued et al., 2014]. The con-
traction of the sheath leads to ejection of the needle (Fig. 1.7 e). How the contraction movement
is transferred from the T6S tubule to the Hcp needle is not known, yet, mutation of conserved
residues at C-terminus of E. tarda Hcp, that would be located at the interface between the needle
and the surrounding sheath, abrogates T6S secretion [Jobichen et al., 2010].
Effectors are thought to be translocated via the needle complex. The Hcp hexamer has an
inner diameter of 40 Å, enough to accommodate small folded or large partially unfolded proteins
[Mougous et al., 2006, Zoued et al., 2014]. A putative effector protein co-immuno-precipitated
with Hcp in E. tarda [Zheng and Leung, 2007] and Silverman et al. [2013] showed that Hcp
can act as chaperone and substrate receptor for T6S effectors. Additionally, the tail tip protein
VgrG can be functionalized with a C-terminal effector domain [Pukatzki et al., 2007, 2009].
Furthermore, the finding of the PAAR- repeat protein VCA0105 forming the very tip of the T6S
needle lead to the Multiple Effector tRanslocation VgrG model (MERV) [Shneider et al., 2013]:
T6S effectors are delivered by translocation through the Hcp needle, or the needle proteins
VgrG and VCA0105 are functionalized either covalently or non-covalently by additional effector
domains or proteins.
1.6.3 Disassembly
The AAA+ ATPase ClpV is recruited to the T6S tubule upon contraction [Basler and Mekalanos,
2012, Kapitein et al., 2013]. It recognizes a special binding motif on VipB and disassembles the
VipA/B tubule under ATP consumption within 30 - 60 s (Fig. 1.7 f) [Bönemann et al., 2009,
Basler and Mekalanos, 2012, Pietrosiuk et al., 2011, Kapitein and Mogk, 2014]. Also, alternative
disassembly pathways mediated by TagJ and VipA homologues are suggested (see 1.2.2). Only
VipB is targeted by the ATPase, but the VipA/B protomer quickly re-assembles or the complex
is just partially unfolded [Bönemann et al., 2009]. Currently it is not clear, whether individual
protomers are recycled into a new loaded T6S tubule or are degraded, but the observation that
more than one T6S tubule is formed in a cell, suggests a recycling of protomers [Basler and
Mekalanos, 2012, Basler et al., 2012]. Deletion of clpv leads to a 90 % loss of T6S antibacterial
activity in V. cholerae, but the ATPase is not essential [Zheng et al., 2011, Basler et al., 2012].
For example, the Campylobacter jejuni T6S lacks ClpV completely [Lertpiriyapong et al., 2012,
Bleumink-Pluym et al., 2013].
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1.7 Motivation
The current model of the Type VI secretion system is the inverted Myoviridae phage tail [Basler
et al., 2012]. It is based on the structural homology of the T6S core components Hcp, VgrG,
VCA0105 and TssE to contractile bacteriophage proteins forming the tail tube, the needle tip and
the baseplate complex [Leiman et al., 2009, Pell et al., 2009, Lossi et al., 2011, Shneider et al.,
2013]. Furthermore, the VipA/B tubule which is a functional homologue of the viral contractile
tail sheath [Basler et al., 2012], is assumed to be also structurally homologous to the tail sheath
protein. This assumption is based on the similar appearance of VipA/B tubules [Bönemann
et al., 2009] and the T4 tail sheath [Moody, 1967] in negative stain micrographs of tubule top
views [Leiman et al., 2009] and in negative stain side view class averages, on a computational
structural homology prediction of the C-terminal part of VipB [Lossi et al., 2013], and on a low
resolution cryo-ET average of the contracted VipA/B tubule with right-handed helical ridges
[Basler et al., 2012]. The exact architecture of the VipA/B tubule, as well as the structure and
arrangement of VipA and VipB in the asymmetric unit are not known yet.
One hallmark of Type VI secretion system is the AAA+ ATPase ClpV [Schlieker et al.,
2005]. It is dedicated to the disassembly of contracted VipA/B tubules for recycling by inter-
acting with VipB [Bönemann et al., 2009, Pietrosiuk et al., 2011, Basler and Mekalanos, 2012,
Basler et al., 2012, Kapitein et al., 2013]. Generally, a loss of ClpV leads to a reduced Type VI
secretion activity and tubule mislocalization [Zheng et al., 2011, Basler and Mekalanos, 2012,
Basler et al., 2012, Kapitein et al., 2013].
Additionally, the Type VI secretion system plays an important role in inter-bacterial compe-
tition[Basler et al., 2013, Ho et al., 2013, Russell et al., 2014b], thereby enhancing host coloniza-
tion [Fu et al., 2013, Ma et al., 2014], and can also be directed against eukaryotic cells [Pukatzki
et al., 2006, Bröms et al., 2009, Ma et al., 2009a, Aubert et al., 2010, Ma and Mekalanos, 2010,
Bröms et al., 2012]. Furthermore, other phage tail-like structures are employed by bacteria
in virulence such as the PVC/Afp structures [Yang et al., 2006, Hurst et al., 2007, Rybakova
et al., 2013] and R-type pyocins [Michel-Briand and Baysse, 2002]. And finally, there is also
little high-resolution structural data on the assembly of phage tails themselves available [Leiman
et al., 2004, Kostyuchenko et al., 2005, Aksyuk et al., 2009, 2011, Effantin et al., 2013, Leiman
and Shneider, 2012]. This makes the proteins in the contractile machinery an interesting target
for research and - in the case of pathogens - drug targeting for which structural data is vital.
Since VipA and VipB proteins could not be crystallized so far due to their tubule-forming
nature, their structure is elucidated in the tubule complex by cryo EM. Therefore, V. cholerae
VipA/B tubules are heterologously expressed in E. coli and purified after a protocol established
by Bönemann et al. [2009]. The tubules are vitrified and cryo EM data collected which is the
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basis for a single particle reconstruction employing helical symmetry [Egelman, 2007b, Clare
and Orlova, 2010]. The VipA/B protomer is isolated from the EM density and a structural
model obtained in which the ClpV interaction site is localized. The structural model is used to
gain insights into the mechanisms behind tubule contraction and recycling.
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2.1 Material
2.1.1 Chemicals and reagents
Chemicals and reagents used in this work have been purchased from Carl Roth GmbH & Co.
KG (Karlsruhe, Germany), Sigma Aldrich (St. Louis (MO), USA), Merck KGaA (Darmstadt,
Germany), Serva Electrophoresis GmbH (Heidelberg, Germany) or VWR (Radnor (PA), USA)
unless stated otherwise. Cell culture media components have been purchased from ForMedium
(Norfolk, UK).
2.1.2 Strains and plasmids
The genetic background of E. coli strains used in this work is listed in table 2.1. E. coli strains
are presented in table 2.2. Strains provided by the group of A. Mogk at the DKFZ Heidelberg
are indicated (*).
Table 2.1: Genotype of E. coli strains used in this work.
Strain Genotype Source
BL21-DE3 F- ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI
lacUV5-T7 gene 1 ind1 sam7 nin5])
Studier and Moffatt,
1986
DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG
Φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK-
mK+), λ–
Grant et al., 1990
MC4100 F- [araD139]B/r Δ(argF-lac)169* &lambda- e14-
flhD5301 Δ(fruK-yeiR)725 (fruA25)‡ relA1
rpsL150(strR) rbsR22 Δ(fimB-fimE)632(::IS1) deoC1
Peters et al. 2003
XL1 endA1 gyrA96(nalR) thi-1 recA1 relA1 lac glnV44 F’[
::Tn10 proAB+ lacIq Δ(lacZ)M15] hsdR17(rK- mK+)
Stratagene
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2 Material and Methods
2.1.3 DNA primer sequences
DNA primer sequences have been purchased from metabion GmbH (Planegg, Germany) and are
presented in table 2.3.
Table 2.3: DNA primer sequences and their annealing temperatures used in the PCR experiment.
name sequence annealing
temperature
E375C_for 5’- CCA AAT ACC AAA TGT GGC AAA GAA GCG -3’ 55°C
E375C_rev 5’- CGC TTC TTT GCC ACA TTT GGT ATT TGG -3’ 55°C
P390I_for 5’- TTG GGT ACC CAG CTG ATC TAC ATG ATG ATC -3’ 53°C
P390I_rev 5’- GAT CAT CAT GTA GAT CAG CTG GGT ACC CAA -3’ 53°C
2.1.4 Antibodies
Antibodies used for Western blot detection and labeling experiments are listed in table 2.4.
Table 2.4: Antibodies used in this work.
antibody manufacturer
αHis (mouse) dianova GmbH, Hamburg, Germany
αHA High Affinity Roche Diagnostics Deutschland GmbH, Mannheim, Germany
α-mouse, HRP-conjugated (rabbit) Santa Cruz Biotechnology, Inc., Dallas (TX), USA
2.1.5 Proteins
V. cholerae proteins that have been purified by our collaborators A. Mogk and
colleagues are presented in table 2.5.
Table 2.5: Proteins from A. Mogk and colleagues used in this study.
Protein Source
ClpV Bönemann et al., 2009
His6-VipA-HA/VipB Kube et al., 2014
ClpV-N(A86C)/VipA/VipB(T27C) Kube et al., 2014
VipA/VipB(E375C) Kube et al., 2014
VipA/VipB(Q429C) Kube et al., 2014
VipA/VipB(E375C/Q429C) Kube et al., 2014
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2.2 Methods
2.2.1 Cell culture methods
Proteins are expressed in E. coli. Cultivation methods are described below. All media are au-
toclaved before use and supplemented with antibiotics dependent on the selection markers (see
table 2.6) unless stated otherwise. Antibiotics are dissolved in ddH2O, sterile filtrated and stored
at -20 °C.
Table 2.6: Antibiotic supplement according to plasmid used.
plasmid antibiotic final concentration
pQE31 Ampicillin 100 µg/mL
pLacIQ Spectinomycin 50 µg/mL
2.2.1.1 Cultivation of E. coli strains
For plasmid isolation, 2 mL of 2YT medium (see table 2.7) are inoculated with a single bacterial
colony picked from a LB agar plate (see table 2.8). The culture is incubated at 37 °C and 120 rpm
overnight on a shaker.
For protein purification, 25 mL of 2YT medium per 1 L of expression culture is inoculated
with the E. coli protein expression strain. The starter culture is incubated at 37 °C and 120 rpm
overnight. The expression culture is inoculated with starter culture and incubated at 37 °C and
120 rpm until an OD600 between 0.6 to 0.8 is reached. Then, protein expression is induced by
adding IPTG to a final concentration of 1 mM. The cells are harvested after 3 h incubation at
37 °C and 120 rpm by centrifugation for 10 min at 4,000 rpm (3.501 x g) and 4 °C on a Sorvall
RC Evolution centrifuge (Thermo Fisher Scientific, Inc., Waltham (MA), USA) using the SCL-
6000 rotor. The cell pellet is resuspended in 20 mL to 40 mL of supernatant and centrifuged
at 4,000 rpm (5,063 x g) for 20 min and 4 °C. The supernatant is discarded and cell pellets are
stored at -80 °C until further use.
Table 2.7: 2YT medium.
16 g Bacto trypton
10 g yeast extract
5 g NaCl
ad 1L dH2 O
adjust to pH 7.5
Table 2.8: LB medium for agar plates.
10 g Bacto trypton
5 g yeast extract
6 g NaCl
15 g agar
ad 1L dH2 O
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2.2.1.2 Cryo conservation of E. coli strains
1 mL of E. coli overnight culture is mixed thoroughly with 400 µL of autoclaved 80% glycerol.
Cells are stored at -80 °C.
2.2.2 Molecular biology methods
DNA is treated according to the methods described below.
2.2.2.1 Plasmid isolation
Plasmids are isolated from overnight cultures of DH5α cells using the QIAGEN Spin Miniprep
kit (QIAGEN, Venlo, Netherlands) according to instructions provided by the manufacturer.
2.2.2.2 Site-directed mutagenesis
Mutations are introduced into DNA sequences by site-directed mutagenesis in a PCR reaction
with mismatch primers. A 50 µL reaction is composed as follows:
0.2 - 3.0 µL 30 -80 ng/µL DNA template
5 µL 10x Pfu buffer supplemented with 20 mM MgSO4 (Thermo Fisher Scientific, Inc.,
Waltham (MA), USA)
0.5 µL forward primer 25 pmol/µL
0.5 µL reverse primer 25 pmol/µL
1 µL 10 mM dNTP mix (Thermo Fisher Scientific, Inc., Waltham (MA), USA)
1 µL 2.5 U/µL Pfu DNA Polymerase (Thermo Fisher Scientific, Inc., Waltham (MA), USA)
ad 50 µL ddH2O (autoclaved)
PCR reactions are incubated on a Biometra T1 Thermocycler (Analytik Jena AG, Jena,
Germany) using the following program:
lid temperature: 110 °C preheating on
1x 95 °C 30 s
18x 95 °C 30 s
55 °C 1 min adapt annealing temperature to primer (see table 2.3)
68 °C 11 min 20 s
1x 68 °C 1min
store at 4 °C
The PCR product is checked by electrophoresis on a 0.8 % agarose gel (see 2.2.2.6) and
30 µL of the PCR reaction are digested with FastDigest DpnI (Thermo Fisher Scientific Inc.,
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Waltham (MA), USA) overnight at 37 °C. After digestion, E. coli DH5α cells are transformed
using 10 µL of the digestion reaction (see 2.2.2.3) and as a control 10 µL of the PCR reaction,
respectively. Then, the plasmid is isolated from single clones (see 2.2.2.1) and positive clones
are identified by Sanger sequencing (GATC Biotech AG, Constance, Germany). In the case of
the mutant P390I, in which also an additional PvuII restriction site is introduced, positive clones
are also investigated by restriction digestion (see 2.2.2.4) using the enzymes PvuII-HF (NEB
Inc., Ipswich (MA), USA) and HindIII (NEB Inc., Ipswich (MA), USA).
2.2.2.3 Transformation of chemo-competent E. coli strains
Chemo-competent E. coli cells are transformed following an adapted protocol by Hanahan
[1983]. 50 µL of DH5α cells are incubated with 5 - 10 µL of plasmid DNA for 15 min on
ice. Afterwards, the cells are heat-shocked at 42 °C for 2 min and cooled down for 2 min on ice.
500 µL of pure 2YT medium are added to the cells. After an incubation period of 1 h at 37 °C
and 120 rpm, the cells are pelleted by centrifugation for 1 min at 13,000 rpm (15,871 x g). The
pellet is resuspended in 50 µL of the supernatant and plated on LB agar plates supplemented
with ampicillin. The plates are incubated overnight at 37 °C. For transforming BL21-DE3 cells,
the protocol is modified. 100 µL of competent cells are incubated with 5 µL of plasmid DNA
for 30 min on ice, 900 µL of 2YT are added after the cool-down, and the cells are subsequently
incubated for 30 min at 37 °C.
2.2.2.4 Restriction digestion
A 20 µL restriction preparation is composed as follows:
3 µL 30 -80 ng/µL DNA
2 µL 10x buffer as indicated by the manufacturer
1 U of each restriction enzyme
ad 20 µL ddH2O (autoclaved)
The sample is incubated for at least 2 h at 37 °C.
2.2.2.5 DNA concentration determination
DNA concentration and purity is determined by measuring absorption at 260 nm and 280 nm
using a NanoDrop 1000 Spectrometer (Thermo Fisher Scientific Inc., Waltham (MA), USA).
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2.2.2.6 Agarose gel electrophoresis
DNA samples are electrophoretically separated on a 0.8 % agarose gel stained with DNA Stain
G (Serva Electrophoresis GmbH, Heidelberg, Germany) in 1x TBE running buffer (see table
2.9). DNA samples are mixed with 5x DNA loading buffer (see table 2.10) before the run.
Electrophoresis is run at 120 V for 45 min on a PerfectBlue gel system Mini M (Peqlab Biotech-
nologie GmbH, Erlangen, Germany). Gels are documented on a SafeLab Imager (Intas Science
Imaging Instruments GmbH, Göttingen, Germany). Gene Ruler DNA ladder (Thermo Fisher
Scientific Inc., Waltham (MA), USA) is used as a size marker for DNA fragments.
Table 2.9: 10x TBE buffer.
900 mM Tris-HCl pH 8.0
900 mM boric acid
10 mM EDTA
Table 2.10: 5x DNA loading buffer.
10 % (v/v) glycerol
50 % (v/v) 10x TBE buffer
a pinch of bromophenol blue
2.2.3 Protein biochemistry methods
Proteins are purified and analyzed using the methods described below.
2.2.3.1 SDS polyacrylamid gel electrophoresis
Table 2.11: Stacking and separating gels composition. Volumes are sufficient for two gels.
stacking gel 12 % separating gel 15 % separating gel
ddH2O 3.05 mL 3.5 mL 2.35 mL
0.5 M Tris pH 6.8 1.25 mL -
1.5 M Tris pH 8.8 - 2.5 mL
10 % (w/v) SDS 50 µL 100 µL
acrylamid 650 µL 4 mL 5 mL
10 % (w/v) APS 50 µL 50 µL
TEMED 5 µL 5 µL
SDS polyacrylamid gel electrophoresis (SDS-PAGE) is performed following a modified protocol
by Laemmli [1970]. Stacking and separating gels are composed as presented in table 2.11 and
polymerized for 30 min before usage. Protein samples are mixed with 4x Laemmli loading buffer
(see table 2.12) incubated at 95 °C for 5 min before electrophoretic separation at 200 V for 1 h
in 1x Laemmli running buffer (see table 2.13) on a Mini-Protean Tetra Cell system (Bio-Rad
Laboratories, Inc. Hercules (CA), USA). NEB Prestained Protein Marker Broad Range (NEB,
Inc., Ipswich (MA), USA) and Roti-Mark Standard (Carl Roth GmbH & Co. KG, Karlsruhe,
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Germany) are used as a size marker for proteins. In case of a non-reducing SDS-PAGE, DTT is
omitted from the 4x Laemmli loading buffer.
Table 2.12: 4x Laemmli loading buffer.
200 mM Tris-HCl pH 6.8
50 % (v/v) glycerol
4 % (w/v) SDS
10 mM DTT
a pinch of bromophenol blue
Table 2.13: Laemmli running buffer.
25 mM Tris-HCl
200 mM glycin
0.1 % (w/v) SDS
2.2.3.2 Protein precipitation with trichloroacetic acid and SDS
For SDS-PAGE followed by Western blotting, protein samples are precipitated with trichloroacetic
acid (TCA) and SDS. Each Protein sample is mixed gently with each 100 µL of 72 % (w/v) TCA
and 0.15 % (w/v) of SDS, respectively. Subsequently, it is incubated for 15 min at room temper-
ature and then centrifuged for 10 min at 13,200 rpm (16,363 x g) and 4 °C. The pellet is washed
with 500 µL of chilled acetone and centrifuged for 5 min at 13,200 rpm (16,363 x g) and 4 °C.
Afterwards, the supernatant is discarded and the pellet is dried at room temperature, before it is
resuspended in 20 - 50 µL volume of 1x Laemmli loading buffer.
2.2.3.3 Coomassie Brilliant Blue stain
Polyacrylamid gels that are not used for Western blotting are stained with Coomassie Brilliant
blue. The gel is shortly boiled in 20 mL Coomassie staining solution (see table 2.14) and subse-
quently incubated for 20 min at room temperature on a shaker. Afterwards, the gel is destained
in destaining solution (see table 2.15) at room temperature on a shaker until bands are clearly
visible.
Table 2.14: Coomassie staining solution.
45 % (v/v) methanol
10 % (v/v) acetic acid
0.25 % (w/v) Coomassie Brilliant Blue R-250
filter before use
Table 2.15: Destaining solution.
45 % (v/v) methanol
10 % (v/v) acetic acid
2.2.3.4 Silver stain
For the chemical cross-link titration experiments, polyacrylamid gels are stained with colloidal
silver. The gel is incubated in 50 % (v/v) ethanol for 20 min, followed by another 20 min in
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5 % (v/v) ethanol. Then, it is soaked in 35 µM DTT solution for 5 min and in 40 mL of freshly
prepared silver nitrate solution (see table 2.16) for 10 min. Afterwards the gel is rinsed twice
with ddH2O and twice with 25 mL of chilled developing solution (see table 2.17). Gel bands are
developed to the desired darkness by incubating the gel in 50 mL of chilled developing solution.
The reaction is stopped by adding citric acid powder until the solution is saturated. The gel is
soaked in this solution for 10 min.
Table 2.16: Silver nitrate solution.
0.1 % (w/v) silver nitrate
0.0037 (v/v) formaldehyde
Table 2.17: Developing solution.
283 mM Na3CO3
0.0185 % (v/v) formaldehyde
2.2.3.5 Amido black stain
Table 2.18: Amido black staining solution.
0.1 % (w/v) Amido black 10B
40 % (v/v) methanol
10 % (v/v) acetic acid
Protein on nitrocellulose membranes is un-
specifically stained with Amido black 10B.
The blot membrane is soaked with 45 mL of
ddH2O supplemented with 5 mL of amido
black staining solution (see table 2.18) for
5 min at room temperature. The membrane
is subsequently rinsed with ddH2O to remove excess stain.
2.2.3.6 Western blot
Protein from unstained SDS-PAGE gels are electrophoretically transferred onto nitrocellulose
membranes by semi-dry Western blotting (modified after Burnette, 1981). For a description
of the antibodies used in the experiments please see table 2.4. The nitrocellulose membrane
(Whatman Protran BA 85, GE Healthcare, Little Chalfont, UK) and four filter papers (MN 218
B, Macherey-Nagel GmbH & Co. KG, Düren, Germany), all cut to the size of the separating gel,
are soaked in blotting buffer (see table 2.19). Two filter papers are placed on top of each other
onto the anode plate of a PerfectBlue semi-dry electroblotter (Peqlab Biotechnologie GmbH,
Erlangen, Germany), above which the nitrocellulose membrane followed by the gel, two layers
of filter paper and the cathode plate are placed. Proteins are transferred onto the membrane for
90 min in a electric current of 400 mA. Afterwards, the membrane is stained with amido black
(see 2.2.3.5) and an image of the stained membrane is taken. Unspecific binding of protein is
blocked by incubating the membrane for 30 min at room temperature in 5 % (w/v) milk powder
solution. Then, primary αHis antibody is added to the milk powder solution (final dilution
1:1,000) and the membrane is incubated overnight at 4 °C. This step is omitted when αHA
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antibody is detected in gradient profiles directly with secondary α-mouse antibody conjugated
to HRP. The membrane is washed three times with 20 mL of TST buffer (see table 2.20) and
then incubated with secondary antibody diluted 1:10,000 in 5 % (w/v) milk powder solution for
2 h at room temperature followed by another three washing steps with 20 mL of TST buffer.
Finally, the membrane is rinsed with ddH2O. HRP chemiluminescence activity is detected on
hyperfilm (Amersham Hyperfilm ECL, GE Healthcare, Little Chalfont, UK) after incubating the
membrane for 1 min in a mixture of 10 mL of ECL solutions A and B (see tables 2.21 and 2.22),
respectively.
Table 2.19: Blotting buffer.
12.5 mM Tris
100 mM glycine
20 % (v/v) methanol p.a.
0.05 % (w/v) SDS
Table 2.20: TST buffer.
50 mM Tris-HCl pH 7.4
150 mM NaCl
0.1 % (v/v) Tween 20
Table 2.21: ECL solution A.
100 mM Tris-HCl pH 8.5
0.4 mM coumaric acid
2.5 mM luminol
Table 2.22: ECL solution B.
100 mM Tris-HCl pH 8.5
0.007 % (w/v) H2O2
2.2.3.7 Cell lysis by microfluidization
Table 2.23: Lysis buffer
50 mM NaH2PO4 pH 8.0
300 mM NaCl
5 mM β-mercapto-ethanol
For the lysis, the E. coli cell pellet is resus-
pended in 10 mL of freshly prepared lysis
buffer (see table 2.23) per 5 g of cell mass.
The lysis buffer is supplemented with cOm-
plete EDTA-free protease inhibitor tablets ac-
cording to the instructions of the manufac-
turer (Roche Diagnostics Deutschland GmbH, Mannheim, Germany). The cells are mechani-
cally disrupted in 3 to 4 cycles in a microfluidizer (Microfluidics, Westwood (MA), USA) oper-
ated at 103 MPa.
2.2.3.8 Immobilized metal ion chromatography (IMAC)
VipA/B tubules are co-purified with the poly-histidine tagged N-terminal domain of ClpV as
established by Bönemann et al. [2009]. The cell lysate is centrifuged for 25 min at 18,000 rpm
(38,724 x g) and 4 °C on a Sorvall RC Evolution centrifuge (Thermo Fisher Scientific Inc.,
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Waltham (MA), USA) using the SS-34 rotor, while 1.5 mL of Ni-NTA agarose bead slurry (QI-
AGEN, Venlo, Netherlands) per 5 g of initially used cell pellet are equilibrated with lysis buffer
(see table 2.23). After the centrifugation, the supernatant is incubated with the equilibrated Ni-
NTA agarose for 1 h at 4 °C on a spinning wheel. The suspension is transferred to an Econo-Pac
chromatography column (Bio-Rad Laboratories, Inc. Hercules (CA), USA) and washed twice
with 10 mL of lysis buffer. Proteins are eluted from the column using five bed volumes of lysis
buffer supplemented with 250 mM imidazole. After the elution, the Ni-NTA agarose is washed
with 20 mL of 1 M imidazole, of ddH2O and of 20 % (v/v) ethanol, respectively. The packed
column is stored at 4 °C.
2.2.3.9 Size exclusion chromatography
Table 2.24: SEC buffer.
50 mM Tris pH 7.5
150 mM KCl
20 mM MgCl2
2 mM DTT
The ClpV N-terminal domain is separated
from the VipA/B tubules by size exclusion
chromatography (SEC) on an equilibrated
HiLoad 16/600 SuperdexTM 200 column (S-
200, GE Healthcare, Little Chalfont, UK) in
SEC buffer (see table 2.24). The combined
IMAC elution fractions are centrifuged for
10 min at 13,000 rpm (15,871 x g) and 4 °C before being loaded onto the column. SEC is
run on an Äkta P-900 system (GE Healthcare, Little Chalfont, UK) at a flow rate of 0.5 mL/min
and a maximum pressure of 0.3 MPa in an 8 °C environment. UV absorption at 250 nm and
280 nm is recorded. Void fractions are collected and analyzed by SDS-PAGE. For vitrification,
fractions are concentrated on Millipore Amicon Ultra centrifugal filters with a molecular weight
cut-off of 100 kDa (Merck KGaA, Darmstadt, Germany). After use, the Äkta system and the col-
umn is washed with 2 column volumes of ddH2O and 2 column volumes of 20 % (v/v) ethanol.
The column is stored in 20 % ethanol. All buffers and solutions are sterile-filtered and degassed
before use.
2.2.3.10 Analytical ultracentrifugation
Table 2.25: Gradient for VipA/B purification.
50 mM HEPES pH 7.5
150 mM KCl
10 % (v/v) or 40 % (v/v) glycerol
Alternatively, VipA/B tubules are purified
from IMAC fractions by analytical ultracen-
trifugation on a 10 - 40 % (v/v) glycerol
gradient (see table 2.25). The gradients are
prepared in 13 x 51 mm Seton open top
PolyclearTMtubes (Science Services GmbH,
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Munich, Germany) and 400 µL of combined IMAC elution fractions are applied. The samples
are ultracentrifuged for 16 h at 33,000 rpm (132,335 x g) and 4 °C in a Beckman L80 Ultracen-
trifuge (Beckman Coulter, Inc., Pasadena (CA), USA) using a SW 55 Ti rotor. Afterwards, the
pellet fraction is resuspended in gradient buffer without glycerol.
2.2.3.11 Protein concentration determination
Protein concentrations are determined using a bicinchomic acid assay (BCA, Thermo Fisher Sci-
entific Inc., Waltham (MA), USA)) according to the instructions provided by the manufacturer.
Protein concentration references are prepared using bovine serum albumin (Sigma Aldrich, St.
Louis (MO), USA) and absorbance at 562 nm is recorded using a Infinite M1000 microplate
reader (Tecan Group Ltd., Maennedorf, Switzerland).
2.2.3.12 Protein cross-linking using Di-sulfo-succinimidyl-glutarate
Before cross linking wild-type VipA/B tubules, VipA/VipBΔC210and VipA/VipBΔC367in batch
for mass-spectrometric analysis, cross-linking conditions are optimized in cross-linker titration
experiments. For this, 3 µg of protein are thoroughly pipette-mixed with isotope-labelled H6/D6
Di-sulfo-succinimidyl-glutarate (DSSG, Creative Molecules, Inc., Victoria, Canada) dissolved
in ddH2O. The final cross-linker concentration is varied. Samples are incubated for 30 min
at 30 °C. Cross-linking reactions are quenched by pipette-mixing with ammonium bicarbon-
ate solution to a final concentration of 100 mM and incubating them for another 30 min at
30 °C. For mass-spectrometric analysis, 180 µg/mL of wild-type tubules are cross-linked in
batch with 0.1 mM and 0.4 mM of DSSG. The truncation mutants (180 µg/mL) are cross-linked
with 0.4 mM DSSG. To further increase the protein concentration of the truncation mutant for
the analysis, truncation mutant samples are concentrated twice on Millipore Amicon Ultra cen-
trifugal filters (Merck KGaA, Darmstadt, Germany) with a 10 kDa molecular weight cut-off.
2.2.3.13 Analysis of protein cross-links by mass-spectrometry
Cross-link mass spectrometry (XL-MS) is performed by T. Zimniak and F. Herzog as described
in Herzog et al., 2012. Cross-linked peptides are analyzed from a tryptic digest of the samples
by LC-MS/MS.
2.2.3.14 Protein cross-linking using glutardialdehyde
Proteins are cross-linked with glutaraldehyde following the GraFix method [Kastner et al.,
2008]. A glycerol gradient is prepared as described (see 2.2.3.10) but additionally glutaralde-
hyde (Carl Roth GmbH & Co. KG, Karlsruhe, Germany) is added to the heavier gradient buffer
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to a final concentration of 0.025 %. Thus, a glutaraldehyde gradient from 0.0 % to 0.025 % is
created. A reference gradient without cross-linker is included into each run to control the migra-
tion of the protein in the gradient. The ultracentrifugation is performed as described above. The
cross-linked sample in the pellet fraction is resuspended in gradient buffer without glycerol and
quenched with Tris-HCl pH 8.0 to a final concentration of 100 mM.
2.2.3.15 Cystein cross-linking of proteins
Cysteine cross-linking experiments are performed by N. Kapitein and A. Mogk at the DKFZ
Heidelberg as described in Kube et al., 2014. Cross-linked cystein mutants ClpV-N(A86C)
and VipA/VipB(T27C) are co-purified without DTT. Mutant complexes VipA/VipB(E375C),
VipA/VipB(Q429C) and VipA/VipB(E375C/Q429C) (each 1 - 5 µM) are reduced with 50 µM
Tris(2-Carboxyethyl)Phosphine) (TCEP) for 30 min at 30 °C. The reducing agent is removed
in PD-10 desalting columns (GE Healthcare, Little Chalfont, UK). Cysteins are cross-linked by
adding copper phenanthroline to a final concentration of 25 - 500 µM and incubating the sample
for 30 min at 20 °C . The reaction is quenched by adding Laemmli loading buffer supplemented
with 5 mM EDTA and 20 mM iodoacetamide. Cross-linked samples are analyzed on a non-
reducing polyacrylamid gradient gel.
2.2.3.16 Analytical protein digestion
Analytical digestion of wild-type VipA/B tubules are performed by N. Kapitein and A. Mogk as
described in Kube et al., 2014. 30 µg of VipA/B are digested in SEC buffer with 8 µg in a 100 µL
reaction volume for 90 min at room temperature. Protein fragments from SDS-PAGE gels are
identified by mass spectrometry and Edman sequencing of protein N-termini (Toplab, Munich,
Germany).
2.2.4 Electron microscopy methods
Various high and low resolution electron microscopic methods are used to investigate the struc-
ture of the VipA/B complex.
2.2.4.1 Glow discharging of EM grids
Carbon coated electron microscopy grids are glow-discharged prior to use in a plasma cleaner
(Harrick Plasma, Ithaca (NY), USA) at a pressure below 29.3 Pa. Grids used for negative stain
are glow-discharged for 45 s, while grids used for cryo EM are glow-discharged for 30 s.
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2.2.4.2 Negative stain
Samples are stained either with 2 % uranyl acetate (Ted Pella, Inc., Redding (CA), USA) or
Nano-W (Nanoprobes, Inc., Yaphank (NY), USA). 3.5 µL of protein sample diluted to a con-
centration of 20 - 50 µg/mL are incubated for 45 s at room temperature on a grid coated with
continuous carbon film (Quantifoil Micro Tools GmbH, Jena, Germany or Plano GmbH, Wet-
zlar, Germany). Excess sample is carefully blotted off using the tip of a circle sector shaped
piece of Whatman #1 filter paper (GE Healthcare, Little Chalfont, UK). 3.5 µL of stain are
applied and blotted off immediately afterwards followed by another 3.5 µL of stain which are
incubated for 15 s on the grid before being blotted off. In the case of Nano-W, a residual volume
of stain is left on the grid which is then air-dried to create a deeper stain.
2.2.4.3 Sample vitrification for cryo EM
Approximately 0.3 mg/mL of protein solution are vitrified in liquid ethane on glow-discharged
Quantifoil R 3/3 holey carbon grids with 2 nm carbon support film (Quantifoil Micro Tools
GmbH, Jena) using a Vitrobot Mark VI (FEI, Hillsboro (OR), USA). Grids are cleaned prior to
use by incubating them for at least 15 min in chloroform. The sample is incubated on the grid
for 45 s at 4 °C and 100 % humidity, and then blotted away with a blot force of 0 for 3.5 s using
two layers of Munktell grade 4b filter paper (Munktell & Filtrak GmbH, Bärenstein, Germany).
2.2.4.4 Labeling of poly-histidine tags by Ni-NTA Nanogold
Wild-type and poly-histidine tagged protein complexes are incubated with Ni-NTA Nanogold
(Nanoprobes, Inc, Yaphank (NY), USA) at a final dilution of 1:50 for 5 min at room temperature.
Afterwards, the sample is stained with uranyl acetate as described in 2.2.4.2.
2.2.4.5 Antibody labeling of HA-tags
Table 2.26: Gradient for antibody removal.
50 mM HEPES pH 8.0
150 mM KCl
10 mM MgCl2
10 or 40 % glycerol
3.3 µM of wild-type and HA-tagged pro-
tein complexes are incubated overnight with
0.09 µM of αHA antibody in a volume of
100 µL at 4 °C. Free antibody is subsequently
removed by ultracentrifugation in a 10 - 40 %
glycerol gradient (see table 2.26) as described
. Resuspended pellet fractions are stained
with Nano-W.
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2.2.4.6 Binding of ClpV to VipA/B
0.9 µM of ClpV are incubated for 5 min at 37 °C with 2.5 µM of VipA/B in the presence of
2.5 mM ATPγS. The sample is stained with uranyl acetate.
2.2.4.7 Collection of negative stain data
Single micrographs are collected on a FEI Morgagni transmission electron microscope (FEI,
Hillsboro (OR), USA) at 80 keV with a SIS Megaview 1K CCD camera. The nominal magni-
fication is 60,000x. Images of antibody labelled tubules and micrographs used for further com-
putational analysis are collected on Tecnai G2 Spirit transmission electron microscope (FEI,
Hillsboro (OR), USA) at 120 keV under low-dose conditions with an Eagle 2,048 x 2,048 pixel
CCD camera (FEI, Hillsboro (OR), USA). The nominal magnification is 96,774 which results
in pixel size of 3.1 Å at the specimen level. The under-focus is varied between 200 - 1,500 nm.
Micrographs of ClpV bound to VipA/B are taken semi-automatically in spot scan series of 4
micrographs per hole using EM-TOOLS software (TVIPS GmbH, Gauting, Germany).
2.2.4.8 Collection of cryo EM data
A total of 12,271 micrographs of vitrified VipA/B are collected on a Titan Krios TEM (FEI,
Hillsboro (OR), USA) with a 4,096 x 4,096 pixel (scan pixel size 15.6 µm) TemCam-F416
CMOS camera (TVIPS GmbH, Gauting, Germany). Images are semi-automatically collected
using the EM-Tools software (TVIPS GmbH, Gauting, Germany) taken under low-dose condi-
tions at 200 keV in spot scan series of 7 micrographs per hole and the under-focus is varied
between 1,000 - 4,500 µm. The pixel size is calibrated to 1.0698 Å using the layer line pattern
of tomato mosaic virus.
2.2.5 Electron microscopy data processing
EM images are further analyzed employing 2D and 3D methods to reconstruct the VipA/B tubule
and to interpret the EM map.
2.2.5.1 Preprocessing of electron micrographs
Contrast transfer functions (CTF) are determined on two times decimated micrographs using
CTFFIND3 [Mindell and Grigorieff, 2003]. Micrographs with more than 16 % astigmatism,
too much contamination or more than 5,000 nm defocus are sorted out automatically or by
visual inspection. Finally, the phases in each image are corrected for the effects of the CTF
in SPIDER [Frank et al., 1996]. Individual images of single particles are selected manually
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in BOXER [Ludtke et al., 1999] with an overlap of 60 % when more than one box could be
placed on a tubule, or semi-automatically in FINDEM [Roseman, 2004] when class averages
from multi-variate statistical analysis are available as a template. For this, micrographs are two
times decimated, filtered between 15 Å and 150 Å and a cross-correlation peak width of 12 Å
was used. The minimal stay away between particle centers was set to 12 Å.
2.2.5.2 Multi-variate statistical analysis and 2D multi reference alignment
Generally, multi-variate statistical analysis and 2D multi reference alignment is done in IMAGIC-
5 [van Heel et al., 1996]. First, images are high-pass filtered to 300 Å, masked, and normalized.
Single particles representing side views of the VipA/B tubule are centered by aligning them to a
centered single image while top views are iteratively centered to their rotational sum. Rounds of
multi-variate statistical analysis and 2D multi reference alignment to selected homogenous class
averages are repeated until alignments are not improving anymore.
2.2.5.3 Determination of the helical symmetry of the VipA/B tubule
Seven long intact tubular sections are extracted from cryo EM micrographs and padded into
4,096 x 4.096 boxes in SPIDER. They are Fourier-transformed and the Fourier-transforms are
summed up. The sum was analyzed by Fourier-Bessel analysis in IMAGEJ [Diaz et al., 2010,
Schneider et al., 2012] giving initial estimates of the helical symmetry parameters. The pa-
rameters are refined in an IHRSR++ 1.4 run [Egelman, 2007a, Parent et al., 2010] with 2,424
manually selected and two times decimated images as an input. The start parameters 21.7 Å unit
rise, 30 ° unit twist and an additional C6 symmetry are refined to 22.2 Å and 29.55 ° after 30
iterations with an angular search increment of 0.1 ° and a translational increment of 0.1 Å. The
refined parameters and the six-fold symmetry are used to obtain an initial 3D reconstruction of
the tubule from class averages of a twice decimated dataset of 7,939 manually selected particles
that are band-pass filtered between 2.2 Å and 320 Å using an adapted protocol of Clare and
Orlova [2010].
2.2.5.4 Reconstruction of the VipA/B tubule
The initial 3D reconstruction (see 2.2.5.3) is used as a starting model for the iterative refinement
of the orientations of 19,954 particles, that have been manually selected from 6,489 micrographs,
by projection matching in SPIDER. Throughout the refinement, the angular sampling is stepwise
reduced to 0.5 ° using C6 symmetry. After each alignment round, 70 - 80 % of all particles are
selected based on their cross correlation coefficient and back-projected using interpolation in
Fourier space (SPIDER command BP 3F). In the last refinement rounds the volume is filtered
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between 15 Å and 5 Å before creating reference projections. Images are classified after mul-
tivariate statistical analysis when 90 % of the assigned angles are stable. Classes are selected
based on their Fourier transform and their 2,328 members are used for the reconstruction result-
ing in a resolution of 8.8 Å after the FSC0.5 criterion with a loose mask applied.
Additional particles are picked semi-automatically from the remaining micrographs and
108,016 particles are selected after multiple rounds of class-editing [Arbeláez et al., 2011]. The
images are pretreated as described and added to the dataset. The merged dataset is refined by
projection matching in SPIDER up to an angular sampling of 0.5 °. Undecimated data is used for
the last refinement rounds and back-projection is performed in real space (SPIDER command BP
RP). Before the last round, the dataset is classified using multivariate statistical analysis and the
best classes were selected based on the amount of high resolution information in their Fourier
transform. 16,394 particles are symmetrized as described [Clare and Orlova, 2010] and used
for the final reconstruction at 5.8 Å resolution (FSC0.5 criterion) which is filtered for display
between 3 Å and 15 Å.
2.2.5.5 “Gold standard “ refinement by regularized likelihood optimization
To check for potential over-refinement of the data, the final dataset of 16,394 particles is two
times decimated and reprocessed according to the “gold-standard” in Relion [Henderson et al.,
2012, Scheres and Chen, 2012, Scheres, 2012a,b]. The dataset is separated into two half-datasets
which are refined independently from each other using regularized likelihood optimization with
a reconstruction from IHRSR as a initial reference. In the first round, the refinement is limited
to 30 Å and only a 6-fold rotational symmetry is employed. Helical parameters are searched
in 3D by cross-correlation for both reconstructions independently and the reconstructions are
symmetrized in 3D.
2.2.5.6 Resolution determination
Except for the “gold standard” reconstructions, the resolution is calculated by determining the
cross-correlation between Fourier shells of volumes reconstructed from half-datasets that are
separated after the last alignment round. The volumes are masked with hollow-cylinders with
the height of one or more ring sections of the VipA/B tubule. Optionally they are additionally
masked with a loose binary mask. An FSC of 0.5 is used as a resolution threshold.
“Gold standard” resolution is determined by calculating FSC between independent recon-
structions. The FSC resolution threshold is 0.143.
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2.2.5.7 Determination of handedness
The hand of the reconstruction is determined by overlaying the homologous C-terminal domain
of the crystal structure 3J2N and the predicted model of the VipB C-terminal domain with the
filtered EM map using the “Fit in Map” function in Chimera [Pettersen et al., 2004]. The overlay
is evaluated visually and by cross-correlation between the structures and the map. Additionally
the Fourier transform sum (see 2.2.5.3) is compared to published Fourier transforms of the T4
phage polysheath [Moody, 1967].
2.2.5.8 Map segmentation and atomic structure fitting
The EM map is segmented manually into protomers using Segger in Chimera [Pettersen et al.,
2004, Pintilie et al., 2010] based on the location of protein termini, the overlay of VipA and
VipB with the density and on the comparison to homologous viral tail sheath structures, 3J2N,
3LML and 3HXL.
3J2N is also used as a template to manually build the secondary structure model of the
VipA/B protomer in Chimera. The C-terminal and middle segment of the structure is overlaid
with the filtered EM map based on the best cross correlation. VipB secondary structure elements
as predicted by PredictProtein [Rost et al., 2004] are built using standard rotamer libraries as
provided by Chimera and placed into the EM density based on correspondences between them
and the gp18 structure. Secondary structure elements of VipA are built accordingly and posi-
tioned into the remaining unfilled density guided by the characteristic helical density attributed
to helix HA3.
2.2.5.9 Map visualization
All EM maps and structures are visualized in UCSF Chimera [Pettersen et al., 2004] except for
figure 3.14 d which is created in PyMol (The PyMol Molecular Graphics System, MacPyMol,
Schrödinger).
2.2.6 Protein structure prediction
VipB structural elements are predicted from their amino acid sequence using HHPred [Söding,
2005] and Quark [Xu and Zhang, 2012]. For HHPred, the C-terminal sequences of VipB (334 -
492 aa), 3J2N (511 - 646 aa), 3LML (307 - 454 aa) and 3HXL (301 - 439 aa) are used as an
initial query resulting in a model of VipB C-terminal region (389 - 492 aa) created in Modeller
[Eswar et al., 2007]. Quark is used to predict the N-terminal 4-helix bundle of VipB (1 - 85 aa).
43
3 Results
3.1 Purification of wild-type VipA/B tubules after
over-expression in E. coli
Images for single particle reconstruction need to be acquired from a homogenous and ordered
protein sample. Two purification protocols for VipA/B tubules are tested for their suitability.
3.1.1 Purification by immobilized metal ion affinity chromatography
(IMAC) and size exclusion chromatography (SEC)
The purification protocol for VipA/B tubules expressed heterologously in E. coli has been estab-
lished by A. Mogk and colleagues who also provided all E. coli strains [Bönemann et al., 2009].
It is based on the binding of the T6S-specific AAA+ ATPase ClpV to VipB via its N-terminal
domain [Pietrosiuk et al., 2011]. The N-terminally poly-histidine tagged N-terminal domain
(1-178 aa) of ClpV (ClpV-N) is co-purified from cell lysate together with VipA and VipB by
IMAC (Fig. 3.1 a) on a Ni-NTA column. Afterwards, selected elution fractions (*) are further
purified in a SEC step on a sephacryl S-200 column (GE Healthcare Life Sciences). Tubular
complexes formed by VipA (18.5 kDa) and VipB (55.6 kDa) elute in the void volume (1), while
ClpV-N (approx. 20 kDa) which constitutes the majority of the purified protein elutes in peak
(2) (Fig. 3.1 b). The histidine-tag of the ClpV-N is detected in fractions of peak (2) but not
in void fractions on a Western blot (Fig. 3.1 c). When stained with 2 % uranyl acetate, void
fractions show fragmented short VipA/B tubules with a diameter of approximately 300 Å on
electron micrographs (Fig. 3.1 d).
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Fig. 3.1: Purification of wild-type VipA/B tubules by IMAC and SEC. (a) N-terminally poly-
histidine tagged N-terminal domain of ClpV (ClpV-N) and VipA/B tubules are co-purified by
IMAC on a Ni-NTA column; CL: cleared lysate, F: flow-through, W: wash fraction, EL: elution
buffer (250 mM imidazole), E1-E6: elution fractions, 1M: elution with 1M imidazole. Marked
(*) elution fractions are treated by SEC on a S-200 column. (b) VipA/B tubules elute in the void
fractions (1) while ClpV-N elutes in peak (2). (c) On a Western blot, the poly-histidine tag is not
detected in the void fractions (1) but in fractions of peak (2). (d) A micrograph of a void fraction
stained with 2 % uranyl acetate shows short VipA/B tubules.
3.1.2 Purification by IMAC and glycerol gradient ultracentrifugation
To separate fragmented VipA/B tubules, the SEC step was substituted by a ultracentrifugation
step on a 10 - 40 % (v/v) glycerol gradient. Here, the histidine tag is detected on a Western blot
of all precipitated fractions of the gradient (Fig. 3.2 a, b). Electron micrographs of the pellet
fraction stained with 2 % uranyl acetate show longer and less fragmented tubules (Fig. 3.2 c).
To be able to employ the helical symmetry of the VipA/B tubule in the cryo EM reconstruc-
tion, either regular binding of ClpV-N to the tubule is needed, i . e. every binding site on the
helical array is occupied, or ClpV-N needs to be completely separated from the tubules. Any ir-
regular binding of ClpV-N disturbs the helical symmetry of the complex and artifacts are created
during symmetrization. The ultracentrifugation protocol is time-efficient and more intact tubules
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Fig. 3.2: Purification of wild-type VipA/B tubules by IMAC and glycerol gradient ultracen-
trifugation. (a, b) Co-purified N-terminally poly-histidine tagged ClpV-N and VipA/B tubules
are treated by glycerol gradient ultracentrifugation. The poly-histidine tag is detected in all frac-
tions and in the pellet (P) of a 10 - 40 % glycerol gradient. (c) A negative stain micrograph
of the pellet fraction stained with 2 % uranyl acetate shows long intact VipA/B tubules. The
experiment has been performed by J. Albrecht.
are obtained, but ClpV-N is still present in the sample and a regular binding of the domain on
VipB cannot be guaranteed. Hence, VipA/B tubules purified by SEC are chosen for vitrification.
In that sample, ClpV-N is not present and tubule fragments are still sufficiently long to allow a
cryo EM reconstruction of the tubule by single particle methods.
3.2 Cryo EM reconstruction of the contracted VipA/B tubule
The VipA/B complex is purified as a helical tubule. Therefore, the exact symmetry of this
complex has to be determined first before a volume is reconstructed from side view images.
3.2.1 Electron microscopy and symmetry determination of vitrified
VipA/B tubules
Micrographs of VipA/B tubules vitrified on holey carbon film with an additional 2 nm car-
bon support film exhibit characteristic top (T) and side views (S, Fig. 3.3, left). The 12-meric
cogwheel-like outline of the tubule top view class average (T, Fig. 3.3, right), which has been de-
scribed for negatively stained single images previously [Bönemann et al., 2009], indicates a C12
or a C6 symmetry. The latter agrees with the tail sheath structures of contractile bacteriophages
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(Myoviridae) which consist of six protofilaments. Contrarily to findings for the P. aeruginosa
T6S system [Lossi et al., 2013], no 13-meric top views are observed. Side view class averages
(S) present a periodic pattern of approx. 44 Å reminiscent of stacked rings.
Helical structures are defined by two symmetry parameters - a unit rise Δz defining the
translation of the asymmetric unit along the helical axis and a unit twist Δφ corresponding to
its rotation around the axis. Projections of helical structures can be separated into two helical
lattices defined byΔz andΔφ. The two lattices are mirror images, one is formed by the front side
of the helical structure, the other one by the back side. In reciprocal space, the periodic lattices
form a layer line pattern which is used to determine the helical parameters from projections of
the structure. The more asymmetric units are included into a projection, the more layer lines
become visible at higher frequencies as the signal-to-noise ratio increases.
Fig. 3.3: Cryo electron microscopy of vitrified
VipA/B tubules. left: Micrograph with inverted
contrast of vitrified VipA/B tubules at approx.
2 µm under-focus. right: Class averages from
multivariate statistical analysis of 12-meric top
(T) and side views (S) presenting a periodic pat-
tern of approx. 44 Å (arrow heads). scale bar:
300 Å.
Therefore, seven projections of long
VipA/B tubules are Fourier-transformed and
their transforms added up to further improve
the signal (Fig. 3.4, 1). Indexing the sum of
transforms by Fourier-Bessel analysis gives
initial estimates of the helical parameters
(Fig. 3.4, 2) [Diaz et al., 2010]. A strong
meridional layer line l3 indicates a unit rise
of 22.1 Å while the Bessel orders |n1| = 11-12
and |n2| = 6-8 of layer lines l1 and l2 together
with the 12-meric appearance of the VipA/B
top views point towards a unit twist of approx-
imately 30 °. The initial estimates are sub-
sequently refined using the IHRSR method
(Fig. 3.4, 3) [Egelman, 2007b, Parent et al.,
2010]. In this method, symmetry parameters
are optimized iteratively in cycles of projec-
tion matching, followed by helical symmetry
parameter determination by minimization of
the mean square-deviation between symmetry-related density voxels and symmetrization of
the reconstructed volume. After the parameter refinement, an initial model is reconstructed
by assigning all symmetry-related positions defined by the optimized helical parameters of
Δz = 22.2 Å and Δφ = 29.44 ° and an additional C6 symmetry to copies of a single class
average as described in Clare and Orlova, 2010 (Fig. 3.4, 4).
47
3 Results
Fig. 3.4: Determination of the helical symmetry and initial model of VipA/B tubules. Seven
long and intact helical sections (1) are cut out from cryo electron micrographs and their Fourier
transforms (FT) summed up. Indexing the FT by Fourier-Bessel analysis [Diaz et al., 2010]
(2) gives an initial estimate of the helical parameters unit rise (Δz) and unit twist (Δφ). (3)
The estimates are refined using the IHRSR [Egelman, 2007b] method with an additional C6
symmetry. The parameters are applied to one class average from multivariate statistical analysis
leading to the initial model (4) used for the refinement.
3.2.2 Cryo EM reconstruction
Starting from the model obtained as described in 3.2.1, the reconstruction is refined initially
using 127,970 single images applying C6 symmetry. However, helical symmetry is used for the
final reconstruction of the VipA/B tubule from the best 16,394 images (Fig. 3.5 a-d). Projections
from the reconstructed volume are in good agreement with class averages from multi-variate
statistical analysis of the dataset (Fig. 3.5 e).
Table 3.1: Helical parameters of the contracted
VipA/B tubule and the T4 phage tail sheath [Aksyuk
et al., 2011].
Δz [Å] Δφ [°] width [Å]
VipA/B contracted 22.2 29.4 290
T4 contracted 16.4 32.9 330
T4 extended 40.6 17.2 240
Six right-handed protofilaments with
a unit rise of 22.2 Å and a unit twist of
29.44 ° form the hollow VipA/B tubule
with an inner diameter of 110 Å and an
outer diameter of 290 Å. Alternatively,
the VipA/B tubule can be described as a
stack of hexameric rings with a height of
44.4 Å and six cogs protruding symmet-
rically from the rim of each ring. The
rings are rotated by 29.44 ° against each other. Thus, each cog is placed in between the cogs of
the neighboring rings giving the tubule a 12-meric outline when seen from the top. Since the
unit twist is slightly smaller than 30 °, the surface ridges formed by the cogs on the outside of
the tubule are left-handed with a pitch angle of 87 °. A previously published tomogram of the
VipA/B tubule with right-handed surface ridges is contrasted by this finding [Basler et al., 2012],
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but earlier studies of polysheath-like structures in Alcaligenes eutrophus with a left-handed pitch
angle of 86 ° are consistent with it [Walther-Mauruschat and Mayer, 1978].
The overall architecture of the VipA/B tubule is similar to that of the contracted T4 phage
tail sheath which can be also seen from the comparison of the helical parameters as presented in
table 3.1. Hence, it is assumed, that the reconstructed VipA/B tubule represents the contracted
form. In fact, when T4 tail sheath protein gp18 is heterologously expressed without any other
proteins of the phage, it assembles into long tubular structures called polysheaths that are very
similar to the contracted form of the sheath [Kellenberger and De la Tour, 1964, Moody, 1967,
Amos and Klug, 1975].
The resolution of reconstruction is determined by calculating the Fourier shell correlation
(FSC) between reconstructions from half datasets separated after the last alignment round using
a FSC of 0.5 as a cut-off. Depending on the masking and on the number of ring sections included
into the analysis the resolution ranges between 5.4 - 6.3 Å (Fig. 3.6 a). As a control, the same
dataset is two times decimated and reprocessed in RELION according to the “gold-standard”
[Henderson et al., 2012, Scheres and Chen, 2012, Scheres, 2012a,b]. Following this procedure, a
dataset is separated into two halves that are treated independently. FSC between the independent
final models results in a resolution of 5.8 Å with a 0.143 cut-off (Fig. 3.6 b). The local signal
resolution in the final map is additionally investigated in ResMap [Kucukelbir et al., 2014],
showing a resolution range of approximately 4.4 - 6.4 Å in the ring body and of approximately
5 - 11 Å in the cogs of the cross section (Fig. 3.6 c). Finally, the sum of the Fourier transform
of all images in the dataset exhibits layer lines at the expected locations in the spectrum up to a
spatial resolution of 5.5 Å (Fig. 3.6 d). All in all, volume features until a resolution of 6 Å - i.
e. secondary structure elements - can be reliably interpreted.
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Fig. 3.5: Cryo EM reconstruction of the contracted VipA/B tubule. (a) The reconstructed
map at a final resolution of 6.0 Å is filtered between 15 Å and 3 Å and segmented into six
protofilaments (light blue, blue, red, orange, yellow and green) shown as a (b) side view, as a
(c) cut-open, and as a (d) top view. (e) Class averages (approx. 30 members) from multivariate
statistical analysis of the aligned dataset from the final reconstruction are juxtaposed to reprojec-
tions of the reconstruction into the Euler angle directions assigned to the class averages (adapted
from Kube et al., 2014, please see also section 6.3 Reprints).
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Fig. 3.6: Resolution of the reconstructed map. (a) The resolution of ~6 Å of the final recon-
struction was determined by Fourier-shell correlation (FSC) between maps reconstructed from
half-datasets separated after the last alignment and FSC determined between masked (black: 4
ring sections, red: one ring section) or unmasked ring sections (blue). (b) A “gold-standard”
reconstruction in RELION using two times decimated data resulted in a final resolution of 5.8 Å
(orange) compared to 6.8 Å after the described SPIDER protocol (green). (c) Local resolution
determined in ResMap [Kucukelbir et al., 2014] of a ring section is represented in color code
from 2.4 Å (blue) to 11.4 Å (red). (d) A sum of the Fourier transforms of all aligned particles
selected for the final reconstruction shows layer lines visible up to 5.5 Å.
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3.3 Modeling the structure of the protomer in the VipA/B
tubule
There is little structural data on the VipA/B complex available that can be used to interpret the
reconstruction. It is known that VipA and VipB are present in equimolar amounts in the tubule
[Bönemann et al., 2009] and it has been shown in two-hybrid experiments that regions 100 -
122 aa in VipA and 63 - 163 aa in VipB are important for interaction between the proteins [Bröms
et al., 2009, Aubert et al., 2010, Bröms et al., 2013]. However, no structure of homologues of
the two proteins are available. Secondary structure elements can be safely identified in the EM
map at 6 Å resolution, but it is not possible to segment the volume into individual protomers
which is a prerequisite for Cα chain tracing of VipA and VipB in the protomer. Thus, additional
information on the position of protein termini, on the domain topology, and on the individual
structural motifs needs to be acquired in order to build a model of the protomer in a hybrid
methods approach [Lander et al., 2012].
3.3.1 Localization of Protein Termini in the contracted tubule
Protein termini are localized in the tubule complex in two approaches. In a first experiment,
which has been performed by N. Kapitein and A. Mogk (DKFZ Heidelberg), VipA/B tubules
are analytically digested with trypsin. The time course experiment and subsequent identification
of protein termini by mass spectrometry and Edman sequencing (Fig. 3.7 a) demonstrates that
all protein termini except the VipB C-terminus are accessible for the protease. Especially the
VipB N-terminus which is digested until residue 64 is protease-sensitive. Furthermore, a light-
scattering recording shows that the turbidity increases during the digestion process (Fig. 3.7 b),
which suggests that VipA/B are aggregating when treated with trypsin. This is confirmed by
negative stain EM of VipA/B tubules before (Fig. 3.7 c) and after (Fig. 3.7 d) trypsin treatment.
In the second approach, protein termini are labeled in the VipA/B complex and the complex
is investigated on negative stain electron micrographs. Tubules of N-terminally poly-histidine
and C-terminally HA-tagged VipA and wild-type VipB provided by A. Mogk and colleagues
show specific labeling of the poly-histidine tag with 5 nm Ni-NTA-Nanogold on the ring body
of top views (Fig. 3.8 a). However, no labeling is observed on side views of intact tubules. Thus,
the N-terminal tag of VipA is only accessible for Nanogold particles at the end of the tubules.
The HA-tag of the complex is marked with αHA antibodies on the cogs of tubule top views
(Fig. 3.8 b). Unspecifically bound antibody is separated from the sample by ultracentrifugation
as described and the specific presence of the antibody in the pellet fraction of HA-tagged com-
plexes is assured by detection with anti-αHA antibody on Western blots of precipitated gradient
fractions. The orientation of the VipB C-terminus is investigated in VipA/VipB-YFP tubules.
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Fig. 3.7: Analytical tryptic digest of VipA/B tubules. (a) VipA/B tubules are digested with
trypsin and samples are analyzed by SDS-PAGE at indicated time points. Identities of degra-
dation products at 60 min are asserted by mass spectrometry and N-termini are identified by
Edman-sequencing. (b) Turbidity of VipA/B +/- trypsin and trypsin alone is measured over
time. (c, d) VipA/B tubules are analyzed by negative-stain electron microscopy before and after
90 min trypsin treatment. The experiments presented in this figure have been performed by Axel
Mogk and Nicole Kapitein at the DKFZ Heidelberg. The figure is reproduced from Kube et al.
2014, please see also section 6.3 Reprints.
Class averages from multi-variate statistical analysis of top views of this complex show addi-
tional density in the central cavity attributed to the C-terminal YFP fusion of VipB (Fig. 3.8 c).
As a summary of the experiments, VipA termini are accessible from the outside of the tubule
while the C-terminus of VipB points into the central cavity of the tubule (Fig. 3.8 d).
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Fig. 3.8: Localization of protein termini in VipA/VipB tubules. (a) Wild-type and His6-VipA-
HA/VipB are labelled with 5 nm Ni-NTA-Nanogold (Nanoprobes Inc.) and investigated in neg-
ative stain electron microscopy. (b) Wild-type and His6-VipA-HA/VipB are labelled with αHA
antibody (Roche Anti-HA High affinity) and pelleted by gradient ultracentrifugation. Proteins
on Western blots of the centrifugation profiles are stained with Amido black and the antibody
detected with Anti-αHA antibody. Micrographs are taken from the pellet fractions stained with
Nano-W (Nanoprobes Inc.). αHA antibodies are marked with yellow arrows on the micrographs.
Scale bars correspond to a length of 30 nm. (c) VipA/VipB-YFP are purified by gel filtration
and void fraction analyzed by SDS-PAGE (upper left). Top views taken from micrographs (be-
low) of negatively stained VipA/VipB-YFP are classified after multi-variate statistical analysis.
Classes are represented as sums of class members (upper right). The experiment has been per-
formed by J. Albrecht. (d) Approximate localization of VipA N- and C-terminus (red) and VipB
C-terminus (blue) in the reconstruction as seen in a cut-open view. Figures a-c are adopted from
Kube et al., 2014, please see also section 6.3 Reprints.
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3.3.2 Homology modeling
Fig. 3.9: Predicted homologies of the VipB C-terminal region to viral tail sheath proteins.
(a) Known viral tail sheath protein structures 3J2N (green), 3HXL (magenta) and 3LML (yel-
low) are overlaid and show a conserved fold in the C-terminal and middle domains [Aksyuk
et al., 2011]. This figure is adopted from Kube et al., 2014, please see also section 6.3 Reprints.
(b) Structural homology prediction using HHpred [Söding, 2005] results in a homology model of
the VipB C-terminal domain (389-492 aa) based on (c). (c) Alignment of C-terminal sequences
of VipB (334-492 aa), 3J2N (511-646 aa), 3LML (307-454 aa) and 3HXL (301-439 aa). Helical
regions in the structures and the model are underlaid in black and beta strand regions in gray.
Structural similarities have been detected between the C-terminal regions of VipB orthologues
HsiC1-3 in P. aeruginosa and the gp18 family of viral tail sheath proteins which share a con-
served fold in the C-terminal and middle domains [Aksyuk et al., 2011, Leiman and Shneider,
2012, Lossi et al., 2013]. Accordingly, based on an alignment of the C-terminal regions of VipB
(334 - 492 aa) and the viral tail sheath proteins gp18 (511 - 646 aa, 3J2N), LIN1278 (307 -
454 aa, 3LML) and DSY3957 (301 - 439 aa, 3HXL), a homology model of the C-terminal
domain of VipB (389 - 492 aa) is predicted in HHPred and Modeller (Fig. 3.9) [Söding, 2005,
Webb and Sali, 2014]. The partial structural similarity of VipB to viral tail sheath proteins is
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subsequently used to segment the EM map, to confirm the hand of the reconstruction and to
build a full secondary structure model of the VipA/B protomer.
3.3.3 Hand confirmation
Fig. 3.10: Hand of the reconstruction. (a) The layer lines (upper image, yellow arrows) in the
Fourier transform of VipA/B tubules (upper left) defining the left-handed helical ridges (lower
left: red line) show opposite handedness to the corresponding reflections in Fourier transforms
of images of the contracted T4 phage tail (upper right, adapted from Moody [1967], please
see also section 6.3 Reprints) with right-handed helical ridges (lower right, EMD-5528). The
Fourier transforms are overlaid by the near and the far side of the helical net marked in red and
blue, respectively. (b) The C-terminal domain of gp18 (552-646 aa, green) and the structurally
homologous C-terminal domain of VipB (389-492 aa, blue) fit equally well into the density
corresponding to one VipA/B subunit of the right-handed VipA/B reconstruction shown in slices
at the indicated positions.
As mentioned before, the surface ridges on the contracted VipA/B tubule show opposite hand-
edness to a previously published tomogram. The correct hand of the reconstruction is confirmed
by two observations. Firstly, the first layer line in the Fourier transform of the VipA/B tubules
that defines the surfaces ridges is handed oppositely to the corresponding layer line in a Fourier
transform of contracted T4 phage tails (Fig. 3.10 a, reproduced from Moody [1967]). Likewise,
the surface ridges on both structures are handed oppositely - i. e. even though both structures
are right-handed, the contracted VipA/B tubule bears left-handed surface ridges while the ridges
on the contracted T4 phage tail are right-handed. Secondly, the C-terminal domain of gp18 fits
only into the protomer density of the right-handed VipA/B reconstruction (Fig. 3.10 b).
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Fig. 3.11: Predicted structure of the VipB N-terminus. The N-terminal region of VipB (1 -
85 aa) forms a 4-helix bundle as predicted by Quark [Xu and Zhang, 2012] which fits well into
the density formed by the cog of the density. The protomer is shown from the side (left) and as
seen from inside of the tubule (right). This figure is adapted from Kube et al. 2014, please see
also section 6.3 Reprints.
3.3.4 Secondary structure model
The density of one protomer is segmented from a protofilament by overlaying the gp18 struc-
ture 3J2N with the EM density based on the localization of the homologous C-terminal domains
in the density. The protomer density measures approximately 90 Å from top to bottom and
is approximately 55 Å wide (Fig. 3.12 a). Furthermore, the overlay shows that the structural
similarity extends beyond the C-terminal domain in VipB (VipB-C). The gp18 middle domain
(gp18-M) architecture resembles the middle region up to Helix HB6 of VipB (VipB-M) (Fig.
3.12 b, c). However, the protease-resistant insertion domains gp18-PRFI/II have no correspon-
dence in VipB. As a consequence, the gp18 core structure including the gp18-C and gp18-M is
used as a template to trace the VipB peptide chain of VipB-C and VipB-M (170 - 492 aa).
Ab initio modeling of the VipB N-terminus (VipB-N, 1 - 85 aa) using Quark [Xu and Zhang,
2012] results in a 4-helix bundle that fits very well into the density forming the cog region of
the protomer (Fig. 3.11). A well defined α-helical density corresponding to helix HB5 connects
VipB-M with VipB-N. Modeling of VipA into the remaining density is guided by the long helix
HA3 that spans 25 residues. The only position that can hold this long helix is the large helical
density above HB4 and HB5 crossing the connecting density between the core of VipB and the
cog region. Following the trace of VipA, the β strand rich N-terminal region is in contact with
HB11 and the central β sheet region of VipB-M consisting of strands SB4 to SB6.
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Fig. 3.12: Subunit architecture and secondary structure model of the VipA/B protomer. (a)
One protomer in an isolated protofilament of the VipA/B tubule is segmented into densities at-
tributed to VipA (red) and VipB (blue) as seen from the top. (b) The VipA/B protomer and gp18
(derived from 3J2N) are presented as topology diagrams. VipA and VipB are color-coded as fol-
lows: VipA, red; VipB N-terminal segment, cyan; VipB middle segment, blue; VipB C-terminal
segment, dark blue. The color code for gp18 is as follows: protease-resistant fragment (PRF)
I, green; PRF II, orange; middle segment, blue; C-terminal fragment, dark blue. This figure is
adopted from Kube et al. 2014, please see also section 6.3 Reprints. (c) The secondary structure
model of the VipA/B protomer is color-coded as in (b) and secondary structure elements are
labeled as in figure 3.13. (d) gp18 (3J2N) is fitted into to the protomer density. (e) Slices of the
VipA/B model (left) and gp18 (right) fitted into the density as depicted in the small inset.
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Fig. 3.13: Predicted secondary structure profiles of VipA and VipB. Secondary structure
predictions for (a) VipA and (b) VipB are obtained from PsiPred [Buchan et al., 2013], JPred
[Cole et al., 2008] and PredictProtein [Rost et al., 2004] prediction servers. β sheets are de-
picted in gray and α helices in black. Helices (H) and sheets (S) are numbered as Hx# and Sx#
and color-coded as follows: VipA, red; VipB N-terminal segment, cyan; VipB middle segment,
blue; VipB C-terminal segment, dark blue. Residues of the VipA and VipB sequences that are
deduced to be involved in protomer-protomer contacts in the contracted VipA/B tubules are col-
ored according to figure 3.15. Intra-protofilament contacts are colored in yellow, interprotomer
contacts between consecutive rings in magenta and inter-protomer contacts between protomers
that come to lie on top of each other in the contracted VipA/B tubule in green. This figure is
adopted from Kube et al., 2014, please see also section 6.3 Reprints.
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Helices HA4 and HA5 on the C-terminal region of HA3 are folded back underneath HA3
bringing the C-Terminus of VipA into close proximity to N-terminus of VipB. The close prox-
imity of the C-terminus of VipA to the N-terminus of VipB is consistent with the existence of a
fusion variant of the two proteins which is observed in some proteobacteria such as Hylemonella
gracilis and Burkholderia glumae. Additionally, this fit also agrees with previously published
interaction data between HA3 and VipB [Bröms et al., 2009, 2013, Zhang et al., 2013].
A full secondary structure model of the protomer (Fig. 3.11 d) is built placing secondary
structure elements as predicted by PredictProtein [Rost et al., 2004](Fig. 3.13) following the
traces of the two proteins. Comparing the model and gp18 in an overlay with the VipA/B
protomer as presented in Fig. 3.12 e illustrates the similarities in domain architecture in the
C-terminal and middle domains of the proteins which diminishes until the unique VipB-N and
gp18-PRFI/II domains.
3.3.5 Model validation
The model is validated independently by chemically cross-linking lysines (VipA contains 14,
VipB 29 lysines) with isotope-labelled Di-sulfo-succinimidyl-glutarate (DSSG) and mass spec-
trometric identification of cross-linked peptides (XL-MS) in wild-type VipA/B tubules and two
C-terminal VipB truncation mutant complexes, VipA/VipBΔC210 and VipA/VipBΔC367.
Table 3.2: Summary of cross-link distances x
in the secondary structure model of the VipA/B
protomer.
distance x # cross-links
x < 21 Å 36
21 Å < x < 31 Å 28
not consistent 1
In the truncation mutants, VipB still interacts
with VipA but tubule formation is impaired.
To find optimal cross-linking conditions in
which most lysines form cross-links but few
mono-links are formed, DSSG is titrated (Fig.
3.14 a-c) and samples investigated in SDS-
PAGE and silver staining. With increasing
cross-linking reagent concentration, indicated
bands corresponding to monomers are disap-
pearing, while bands at the expected molec-
ular weight of VipA/VipB heterodimers (×) are appearing in case of the VipB truncation pro-
teins. Multimeric wild-type VipA/B complexes do not form a significant amount of VipA/B
heterodimers when cross-linked, as bands at the expected molecular weight are faint or non-
existent. Here, the attenuation of the monomeric bands is taken as a criterium for the selection
of cross-linking conditions. For the wild-type complex, cross-linking conditions with 0.1 mM
and 0.4 mM DSSG are selected, while the truncation complexes are cross-linked with 0.4 mM
DSSG.
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XL-MS analysis performed by T. Zimniak and F. Herzog reveals that in VipA 13 out of
14 lysines react with the reagent in the form of mono- or cross-links and in VipB 24 of 26. In
total, 83 cross-links are obtained, out of which 65 are distinct: 34 VipA-VipA, 19 VipA-VipB
and 12 VipB-VipB cross-links. 36 cross-links correspond to Cα-Cα distances between cross-
linked lysines below 21 Å which is consistent with the linker length of 7.7 Å plus two times the
length of a lysine side chain (6.5 Å). Furthermore, 28 cross-links cover distances between 21 Å
and 31 Å. This more tolerant distance threshold takes into account hat the VipA/B protomer
model is based on a secondary structure prediction in which shifts in the register of individual
elements are possible and lysines are occurring in flexible loop regions that cannot be placed
reliably into the map. Only one VipA-VipA cross-link representing a homodimer of soluble
VipA is not consistent with the model. Consequently, it is concluded, that the obtained cross-
links generally support the presented secondary structure model. Especially, lysines K100 in
HB5 and K291 in HB11 that form hubs in the cross-link network show multiple connections to
lysines in the N-terminal region of VipA and the C-terminal regions of VipB (Fig. 3.14 d, left).
Also, three cross-links between helix HA3 (103 - 127 aa) of VipA and HB3 and HB4 of VipB
are consistent with a proposed interaction between HB3 and HB8 of VipB and VipA (Fig. 3.14
d, right) [Aubert et al., 2010]. Cross-link distances are summarized in table 3.2. A complete
account of all detected cross-links and their corresponding distances in the protomer model is
presented in section 6 Appendix, table 6.1.
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Fig. 3.14: Cross-link mass spectrometric (XL-MS) analysis of wild-type VipA/B
tubules, VipA/VipBΔC210 and VipA/VipBΔC367. (a) Wild-type VipA/B tubules, (b)
VipA/VipBΔC210 and (c) VipA/VipBΔC367 are treated with DSSG H6/D6 at the indicated con-
centrations and analyzed by silver-stained SDS-PAGE. Cross-linked heterodimers are indicated
(×). Marked samples (*) were subjected to XL-MS analysis. (d) left: Inter-protein cross-links be-
tween VipA and the N-terminal segment of VipB observed in either of the samples are depicted
as black lines between Cα atoms of lysines shown as spheres. right: Inter- and intraprotein
cross-links of VipB lysines K291 and K100 of the samples analyzed are depicted as described
above. The secondary structure model of the VipA/B protomer is depicted as in Figure 3.12.
This figure is adopted from Kube et al., 2014, please see also section 6.3 Reprints.
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3.4 Interprotomer contacts in the contracted VipA/B tubule
Using the validated protomer model, interprotomer contacts are analyzed to elucidate the func-
tion of VipA and VipB in the contractile tubule (Fig. 3.15 a-c). Taking into account the total
contact area, the architecture of the tubule is largely defined by contacts between neighboring
VipB-C domains within a protofilament (yellow marks, Fig. 3.15 a, 3.13) thereby stabilizing the
structure. Furthermore, the N-terminus of VipA is located at the interface between protomers
(cyan circle, Fig. 3.15 a). The protofilaments are interconnected vertically and also diagonally.
Protomers that come to lie directly on top of each other form contacts involving densities at-
tributed to the β sheet rich N-terminus, the long helix HA3 and the connecting loop to HA4 in
VipA, and loops between HB7 to HB9 in VipB (green marks, Fig. 3.15 a,b, 3.13). Consecutive
hexameric rings are connected diagonally by interprotomer contacts involving HB15 and loop
region N-terminal of HB13 (magenta marks, Fig. 3.15 a-c, 3.13).
The latter diagonal contact is supported by in vitro cross-linking experiments using engi-
neered cysteines at E375 in the loop region before HB13 and Q429 in HB15 (inset, Fig. 3.15 c).
When the double mutant VipA/VipB(E375C/Q429C) is treated with the oxidant copper phenan-
throline (CoPhe), the non-reducing SDS gel shows bands at a higher molecular weight where
cysteine cross-linked VipB multimers are expected. The VipA/VipB(Q429C) strain has been
created by N. Kapitein and A. Mogk who also have purified and analyzed the mutant proteins.
Additionally, XL-MS analysis of the cross-linked wild-type VipA/B tubules revealed four cross-
link pairs that are more compatible with interprotomer contacts concerning their bridged Cα-Cα
distances (Fig. 3.15 d).
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Fig. 3.15: Interprotomer contacts in contracted VipA/B tubules. (a) Intra-protofilament con-
tacts in neighboring VipA/B protomers map are shown as top view, inside-out and bottom view.
The middle protomer is segmented into VipA (red) and VipB (blue) densities. The VipA N-
terminus is marked with a cyan circle. (b) Interprotofilament contacts between protomers that
lie on top of each other are presented as side views. (c) Interprotofilament contacts between pro-
tomers of neighboring protofilaments are depicted as seen from inside the tubules. These con-
tacts are investigated in VipA/VipB-E375C/Q429C single and double mutants under reducing
(- copper phenanthroline, CoPhe) and oxidizing (+ CoPhe) conditions by non-reducing SDS-
PAGE (c, inset, the experiment was performed by Nicole Kapitein and Axel Mogk at the DKFZ
Heidelberg). Contact areas for protomer-protomer contacts are highlighted as follows: yellow,
intraprotofilament contacts as seen in (a); green, interprotofilament contacts as seen in (b); ma-
genta, interprotofilament contacts as seen in (c). (d) Intra-protofilament (left) and interprotofil-
ament (middle and right) cross-links as detected in the cross-linking-MS analysis of wild-type
VipA/B tubules. Two protomers with fitted secondary structure elements of VipA (red) and VipB
(blue) are shown in the same orientations as seen in (a–c). The Cα atoms of cross-linked residues
are depicted as spheres and lines indicate cross-links. The figure is reproduced from Kube et al.,
2014, please see also section 6.3 Reprints.
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3.5 Interaction with the AAA+ ATPase ClpV
The T6S system is a one-shot system that is at least partially disassembled by the AAA+ ATPase
ClpV after a contraction event. ClpV binds to a specific recognition motif in helix HB2 at
the N-terminus of VipB via its N-terminal domain and disassembles the contracted VipA/B
tubule [Pietrosiuk et al., 2011]. Even though ClpV is not essential for T6S, T6S-dependent
pathogenecity is attenuated in ClpV-defective mutants [Zheng et al., 2011, Basler et al., 2012].
Thus, the exact binding site of ClpV on the VipA/B tubule is examined in three experiments.
Firstly, co-purified His6-ClpV-N and VipA/B are cross-linked with glutardialdehyde in a
GraFix gradient [Kastner et al., 2008]. Analyzing the gradient fractions by SDS-PAGE and
Western blot shows, that His6-ClpV-N is detected in all gradient fractions whereas His6-ClpV-N
multimers appear only in the upper gradient fractions (Fig. 3.16 a). Typical VipA/B top views
are visible on negative stain electron micrographs of the pellet fraction (Fig. 3.16 b) and multi-
variate statistical analysis of a negative stain dataset results in top view class averages with a
additional density in between the cogs of the VipA/B top view (yellow arrows, Fig. 3.16 c).
Secondly, VipA/B tubules are decorated with hexameric complexes of full-length ClpV
in the presence of slowly hydrolyzing ATPγS [Bönemann et al., 2009] . Class averages of a
negatively stained dataset show that the ATPase is in close contacts with cogs of the tubule (Fig.
3.16 d).
In a third experiment, cysteines are introduced into ClpV-N and the ClpV binding motif
of VipB based on the published structure of the ClpV-N and the corresponding peptide of VipB
(Fig. 3.16 e) [Pietrosiuk et al., 2011]. Mutants ClpV-N(A86C) and VipA/VipB(T27C) have been
created and purified by A. Pietrosiuk and A. Mogk. SDS-PAGE analysis shows that the cysteine
cross-link is dissolved under reducing conditions (Fig. 3.16 f). Comparing class averages of
wild-type tubules and the cross-linked sample in an overlay shows additional density attributed
to ClpV-N(A86C) at the cogs in top views and at the tubule wall in side views (Fig. 3.16
g). Together with the VipA/B protomer model, these results show, that the N-terminal ClpV
recognition motif of VipB is located in the cogs forming the surface ridges of the contracted
tubule.
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Fig. 3.16: Localization of the interaction site of ClpV on the VipA/B tubule. (a) VipA/B
complexes co-purified with ClpV-N by IMAC are treated with the GRAFIX method [Kastner
et al., 2008] on a 10% - 40 % glycerol and 0.0 % - 0.025% (v/v) glutardialdehyde gradient.
TCA-precipitated gradient fractions are examined on a Western blot (left: Amido black stain,
right: detection with αHis antibody, P: pellet fraction). The experiment has been performed by
T. Hassler. (b) Micrograph of the pellet fraction stained with 2% uranyl acetate. (c) Classes
from multivariate statistical analysis of negatively stained VipA/B top views from the pellet
fraction represented as class sums. (d) VipA/B tubules bound to ClpV in the presence of ATPγS
in negative stain are presented as class averages (left: top views, right: side views) derived
from multivariate statistical analysis. (e) The location of cysteine residues used for cross-linking
between VipB (red) and the N terminus of ClpV (blue) are shown on the basis of the crystal
structure PDB ID 3ZRJ. (f) The reduced and oxidized (±DTT) VipA/B/ClpV-N assemblies are
analyzed by non-reducing SDS-PAGE. The experiment has been performed by Nicole Kapitein
and Axel Mogk at the DKFZ Heidelberg. (g) Multivariate statistical analysis of VipA/B tubules
cross-linked to ClpV-N (upper row). The images were binarized and overlaid with images of
class averages of negatively stained wild-type VipA/B tubules (middle row). Additional density
is colored in red and indicated by yellow arrows. Class averages of negatively stained wild-type
VipA/B tubules (lower row). Figures d-f are reproduced from Kube et al., 2014, please see also
section 6.3 Reprints.
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3.6 Comparison to the T4 phage tail sheath: model of the
elongated VipA/B tubule
It is proposed that the T6S tubule formed by VipA and VipB is a functional homologue of bac-
teriophage tail sheaths [Basler et al., 2012] of which the T4 phage tail is characterized the most
thoroughly [Leiman and Shneider, 2012]. In this work, it has been shown that VipB-C and
VipB-M share also structural similarities to gp18 proteins. To visualize the protomer arrange-
ment in the T4 phage tail, the hexameric gp18 model 3J2N [Fokine et al., 2013] is overlaid with
the EM map of the contracted T4 tail sheath (EMD-1086, Leiman et al., 2004). Additionally,
gp18-C and gp18-M domains represented as low-pass filtered electron density maps are fitted
into three consecutive rings of the tail sheath and the T6S tubule into three consecutive rings.
Comparing the two systems in their contracted states shows that the T4 phage tail contracts to a
greater extent (Fig. 3.17 a). While the inner diameter of the T4 tail sheath extends from 100 Å
to 150 Å, the T6S tubule widens from 95 Å only to 110 Å. However, the relative positions of
the C-terminal and middle domains are very similar. The PRFI/II domains of T4 tail sheath pro-
teins gp18 are pointing outwards like the T6S-specific VipB-N domain of the VipA/B protomer
density which is fitted into VipA/B tubule map and rendered at a high threshold. In contrast
to VipB-N in the VipA/B protomer, gp18-PRFI/II domains are turned away from the gp18-M
domain giving the protomer a S-shaped appearance when seen from the top.
To test whether the VipA/B tubule reconstruction represents the system in its fully con-
tracted state, the protomer arrangement of two consecutive protomers in a protofilament in the
T6S system and T4 phage tail is compared. T4 tail sheath protomers rotate approximately 30 °
in plane upon contraction leading to an opening of the inner cavity of the tail sheath (Fig. 3.18
a). The relative position of VipA/B protomers in the contracted state is similar to those of the
T4 tail sheath even though gp18 protomers show an additional rotation around the long axis of
the protomer leading to a smaller helical rise of the contracted tail sheath compared to the T6S
tubule. A superposition of two VipA/B protomers with gp18 subunits that come to lie on top of
each other reveals that VipA/B protomers clash in densities mainly attributed to VipA when the
shallower rise of the contracted T4 tail sheath is enforced upon them (Fig. 3.18 b).
Next, it is asked wether the analogies in the contracted states are found in the elongated
states, too. For this, VipA/B protomer are overlaid with an EM map of the elongated T4 tail
sheath (EMD-1126, Kostyuchenko et al., 2005) based upon the best fit of structurally similar
middle and C-terminal domain of gp18 and VipB. It is assumed that only rigid-body movements
of the protomers occur during contraction [Leiman and Shneider, 2012]. Generally, the sym-
metry of the elongated T4 phage tail is compatible with the VipA/B protomer, even though the
overall protomer architectures are different in the position of the unique domains VipB-N and
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Fig. 3.17: Comparison between contracted VipA/B tubules and T4 phage tail sheaths. (a)
The contracted VipA/B tubule (left) is compared with the contracted T4 tail sheath (EMD-1086;
right) seen as a side view (upper row) and cut-away top view (lower row). The hexameric gp18
model (PDB ID 3J2N, gray) is overlaid with the contracted T4 sheath EM map (EMD-1086,
transparent white) and shown as a side view (top right) and cut-away top view (bottom right).
The low-pass filtered C-terminal and middle segments of gp18 (colored separately) are fitted
into three consecutive rings of the contracted T4 sheath and the VipA/B tubule. One hexameric
gp18 model is depicted as gray crystal structure (right). One VipA/B protomer is rendered at
a high threshold (left) to illustrate the overlay and location of HB2 of VipB (green star). (b,
right) C-terminal and middle gp18 segments are fitted into the elongated T4 sheath EM map
(EMD-1126). The model of the elongated VipA/B is based on the best fit between these and
homologous segments of VipB (left). The elongated VipA/B tubule and T4 sheath are shown
as side (upper row) and top views (lower row). The color code of all maps, models and crystal
structures is as seen in (a). The figure is adopted from Kube et al., 2014, please see also section
6.3 Reprints.
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Fig. 3.18: Protomer arrangement in the VipA/B tubule and the T4 sheath. (a) Protomer
arrangement in protofilaments of extended and contracted T4 tail sheath and VipA/B tubules.
Two consecutive protomers are shown as transparent surface. Low-pass filtered C- and M-
segments of gp18 are fitted into the densities and colored in gray and purple. All dimers are
aligned to the gray gp18 segment. (b) Superposition of two VipA/B protomers onto contracted
T4 sheath subunits that come to lie on top of each other. One VipA and VipB is colored in red
and blue, respectively. Clashes between the protomers are indicated by green arrows. This figure
is reproduced from Kube et al. [2014], please see also section 6.3 Reprints.
gp18-PRFI/II, respectively (Fig. 3.17 b). As a consequence of the differing positions, the VipB-
N domains with the ClpV recognition motif is buried in the tubule wall while the gp18-PRFI/II
domains are still pointing outwards in the elongated states of the tubules.
3.7 Towards the contraction mechanism of the VipA/B tubule
To explore the architecture of the elongated VipA/B tubule, a mutant VipA/B protein is de-
signed, which is speculated to form elongated tubules. As the C-terminal domains are the most
conserved parts in both viral tail sheath proteins and bacterial T6S tubules, they are likely in-
volved in their common function. Comparing two VipA/B protomers in their proposed elongated
and in their contracted state (Fig. 3.19 a) suggests an involvement of helix HB13 (orange) in
the contraction movement. It is located directly in the interface between the VipB C-terminal
domains of both protomers and could possibly move more towards the adjacent protomer in the
elongated state. By this movement, the 90 ° kink between HB14 and HB13 would be relaxed. At
sequence level, a conserved GxxxP motif is located in between the helices which might confer
conformational flexibility. However, when investigating a VipA/VipB(P390I) mutant that was
purified by IMAC and ultracentrifugation, tubules demonstrated a similar diameter as wild-type
tubules, suggesting that they are in a contracted conformation (Fig. 3.19 b).
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Fig. 3.19: Investigation of VipA/B tubule contraction mechanism. (a) upper image: Helix
HB13 (orange) lies at the interface between adjacent protomers (white, green) in one protofil-
ament. During contraction, protomers putatively rotate inwards, with HB13 at the center of
movement; middle image: Predicted structures of C-terminal domains of adjacent protomers
overlaid into the densities of the protomers in the elongated (left) and the contracted state (right);
lower image: sequence of VipB between helices HB13 and HB14 with GxxxP motif in between
predicted helices. (b) Negative stain micrograph of VipA/VipB (P390I) purified by IMAC and
ultracentrifugation. The diameter of the observed tubules is reminiscent of the contracted state.
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Proteins VipA and VipB and their homologues in other bacteria are essential parts of the Type VI
secretion system [Bönemann et al., 2009, Basler et al., 2012]. In the current understanding, the
two proteins form a contractile tubule holding a needle complex which is ejected and penetrates
bacterial membranes to deliver effector proteins. The energy for this action is stored in the
elongated form of the T6S tubule as it is in its functional homologue, the bacteriophage tail
sheath. However, the structures of VipA and VipB, as well as their assembly and functions in
the tubule have not been known so far.
In this work, the contracted T6S tubule of Vibrio cholerae is presented at sub-nanometer
resolution. In a hybrid methods approach, the VipA/B protomer of the tubule is modeled to
the secondary structure level, allowing to compare the bacterial system to its viral counterpart
structurally and also to conclude on functional relationships between their components. This
results in a model of the VipA/B complex in its elongated state suggesting a mechanism for
the observed contraction-state specific disassembly of the T6S tubule [Basler and Mekalanos,
2012].
4.1 The T6S tubule and viral tail sheath have a similar
architecture defined by contacts between structurally
conserved core regions
It has been shown, that T6S components Hcp, VgrG and VCA0105 are structural and functional
homologues of proteins forming the tail tube and the spike of contractile bacteriophages [Leiman
et al., 2009, Pell et al., 2009, Shneider et al., 2013]. Additionally, T6S protein TssE is a structural
homologue of T4 baseplate wedge protein gp25 [Lossi et al., 2011]. Based on these findings and
the appearance of the T6S tubules in negative stain micrographs, it has been suggested that
also the T6S tubule is structurally similar to the T4 tail sheath [Leiman et al., 2009, Lossi et al.,
2013]. Our cryo EM reconstruction of the contracted VipA/B tubule at sub-nanometer resolution
generally corroborates this model.
Both, the T6S tubule and the T4 tail sheath consist of six right-handed protofilaments with
similar helical parameters [Aksyuk et al., 2009, Leiman et al., 2010]. At this level of detail, the
71
4 Discussion
main difference between the two systems is the opposite hand of the helical ridges due to the
different extent of contraction. In the T6S tubule, the helical arrangement is largely governed by
contacts between the C-terminal domains of VipB. The deletion of the C-terminal domain in the
P. aeruginosa homologue completely abrogates tubule formation [Lossi et al., 2013]. This also
holds true for the vcVipA/VipBΔC367 protomers as we confirmed in this study. A similar role in
maintaining the integrity of the phage tail is also suggested for the C-terminal domain (domain
IV) of gp18 [Aksyuk et al., 2009, Leiman et al., 2010, Fokine et al., 2013]. The functional
similarity is mirrored in the structural conservation of the core regions comprising C-terminal
and middle domains in both proteins. The structural conservation is only weakly detectable
on the sequence level for the C-terminal regions [Lossi et al., 2013]. Hence, the parts of the
contractile machinery that are dedicated to maintain the integrity of the structure and most likely
are involved in the contraction process are conserved.
4.2 Tubule contraction mechanism
These structural similarities between the viral and the bacterial system are used to build a model
of the extended state of the VipA/B tubule based on low-resolution EM maps of the extended
T4 phage tail. In the extended state, tubule integrity is still maintained by the close interactions
between VipB C-terminal domains in the protofilaments albeit the interface between neighboring
protomers in a protofilament is changed. Individual protomers of one protofilament are rotated
in plane against each other leading to an opening of the contact zone in the contracted state
putatively involving loop regions SB10-SB11 and HB14-HB15 of one protomer to loop regions
SB11-SB12 and HB13 of the consecutive protomer (Fig. 3.19). Instead, new contacts of SB10-
SB11 and HB14-HB15 to β sheets SB8 and SB9 are formed. Additionally, the contact area
to the first three N-terminal β strands of VipA is extended making new contacts to VipB-C.
Interestingly, a loop region and a β hair pin in gp18 N- and C-terminal of the helix homologous
to HB11 that are in the equivalent position to the VipA N-terminal region, have been shown to be
crucial for tail sheath polymerization [Aksyuk et al., 2009]. Thus, the VipA N-terminal region
which forms intra-protofilament contacts in both states of the tubule might also be involved in
maintaining tubule integrity during the contraction process.
Due to VipA, the VipA/B protomer is bigger than gp18 and as a consequence, the T6S
tubule can contract less compared to its viral counterpart. Comparing the helical parameters of
the contracted forms of both systems shows that the T6S tubule is packed less compact. In situ
measurements of elongated and contracted VipA/VipB tubules result in a length reduction of
45 % during the contraction while the tubule diameter expands to 126 % of its original width
[Basler et al., 2012]. In comparison, the T4 tail sheath contracts by 55 % of its length and ex-
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pands to 138 % of its diameter [Leiman et al., 2010]. However, the T6S tubule is generally
longer than a phage tail and the reduced contraction ability of the system is more than compen-
sated for by its length. It is assumed that the T6S system which can span a complete bacterial
cell, has a maximal penetration length of 500 nm [Ho et al., 2014].
It has been observed that inter-protomer contacts within a protofilament (defined by the C-
terminal regions of gp18) of the T4 tail sheath remain overall unchanged during the contraction
event, while additional contacts between protomers of neighboring protofilaments are created.
This led to the hypothesis that the energy necessary for the contraction is provided by additional
inter-subunit binding and the contraction process only involves rigid-body movements of the tail
sheath proteins [Aksyuk et al., 2009]. However, the comparative model of the extended VipA/B
tubule hints more towards a conformational change in the protomer that drives tubule contraction
and there is indirect evidence from spectroscopic data that the gp18 secondary structure content
changes during contraction of the T4 tail [Venyaminov et al., 1975]. The C-terminal regions of
gp18 and VipB are the most structurally conserved parts in both systems and also positioned
at the hinge region between the two states. This makes them an obvious candidate harboring
a conformational switch, although initial experiments to localize critical amino acids for the
switch failed.
The possibility of linking protomers in a protofilament by “chain-swapping” has been de-
scribed in section 1.6.2. A fit of the structurally conserved domains IV and III of DSY3957 into
the EM density of the contracted and into the model of the elongated VipA/B tubule shows that
- if the “chain-swapping” is not an crystallization artifact (“chain-swapping” tail sheath proteins
in the crystal are not in a helical arrangement) and also conserved in the T6S system - the tubule
geometry would only allow a link between protomers of adjacent protofilaments (Fig. 4.1). A
”chain-swapping” between protomers of the same protofilament is very likely not possible since
the swapped peptide chain originating from the inner wall of the tubule cannot reach the C-
terminal domain of the subsequent protomer as this domain faces the tubule exterior. However,
the linking peptide chain could presumably be accommodated in the connecting density between
protomers of neighboring protofilaments.
In the phage, the N-terminus of the tail sheath protein is involved in the “chain-swapping”,
but the N-terminus of VipB is oriented towards the outer tubule surface and out of reach. In some
bacteria, VipA and VipB occur as a fusion protein in which VipA is located at the N-terminus.
This leaves the β strand rich N-terminus of VipA as the remaining possible candidate to take
over the role of the DSY3957 N-terminus. Even though the proposed secondary structure model
disagrees with this possibility, the obtained cross-link data cannot exclude the alternative fit of
VipA under the assumption that the VipA N-terminus is flexible in the VipB truncation mutants.
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Fig. 4.1: “Chain swapping” hypothesis in the T6S tubule. (a) left: Three VipA/B protomer
densities are displayed in the arrangement according to the model of the elongated T6S tubule
as seen from inside the tubule. Density attributed to VipA in our secondary structure model
of the protomer is shown in red, density attributed to VipB in blue. Protomers 1 (green) and
2 (light blue) belong to the same protofilament (contacts as in Fig. 3.15 a) while protomer 3
(yellow) belongs to the adjacent protomer (contacts as in Fig. 3.15 c). The position of the
DSY3957 N-terminal β strand when fitted into each protomer is marked in magenta and the
connection between neighboring protomers in a possible “chain swapping” model represented
as a broken line. right: Domains IV and III of DSY3957 structure 3HXL are displayed in the
same arrangement. The N-terminal β strand is shown in magenta and the “chain swapping”
connection in broken lines. (b) left: Three VipA/B protomer densities are displayed in the
arrangement according to the EM density map of the contracted VipA/B tubule as seen from
inside the tubule. Connecting density between neighboring protomer is colored in magenta and
marked with a broken line. Color code is defined as in (a). right: Domains IV and III of
DSY3957 structure 3HXL are displayed in the same arrangement. Inset: Chain-swapping of the
DSY3957 (3HXL) when symmetry as observed in the crystal is applied.
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Yet, it is not clear if the N-terminus of VipA would be accessible for a protease as we have
shown in trypsin digestion experiments (Fig. 3.7). Furthermore, Hcp has been shown to interact
with homologues of VipA of EAEC and A. tumefaciens in co-immunoprecipitation and bacterial
two-hybrid experiments [Lin et al., 2013, Brunet et al., 2014]. The interaction site on VipA
has not been localized, but according to our model of the eloganted state and the secondary
structure model of the protomer, the N-terminal region of VipA faces the tubule interior. In the
chain-swapping model involving VipA, the area on VipA to interact with Hcp in the elongated
state would be likely smaller, as the N-terminal region of VipA is bound to an adjacent VipB C-
terminal domain on the outside of the tubule. In summary, the possibility of the chain-swapping
in the VipA/B tubule cannot be completely ruled out, but currently little experimental evidence
argues for it.
4.3 VipA and the VipB N-terminal domain are unique
adaptions of the T6S
The structure of VipA according to the protomer model is completely unrelated to the viral tail
sheath proteins. Thus, its function cannot be deduced from the viral system. In V. cholerae,
VipB is not stably expressed in the absence of VipA and analytical SEC profiles show that the
VipA/B protomer is quickly reassembled after the tubule is taken apart by ClpV in the presence
of ATP [Bönemann et al., 2009]. According to two-hybrid data, the interaction is conserved
throughout species borders and is mainly mediated by helix HA3 of VipA [Bröms et al., 2009,
2013, Zhang et al., 2013]. Impairing this interaction leads to a reduced stability of VipB and
loss of T6S ability [Bröms et al., 2009]. Hence, VipA could serve as a chaperone of VipB. In
the proposed structure of the VipA/B protomer, VipA wraps around the connecting helices HB4
and HB5 between the middle region of VipB and the N-terminal domain and has large contact
areas to VipB at its termini. Thereby, it stabilizes the likely most flexible parts of the protomer,
giving it a rigid structure that can withstand the forces during the quick contraction process.
Furthermore, the N-termini of VipA homologues in P. aeruginosa and S. marcescens are
specifically adapted to interact with the non-essential TagJ protein [Lossi et al., 2012, Forster
et al., 2014]. Recently, ClpV of the P. aeruginosa H1-T6S system has been shown to inter-
act with TagJ homologue HsiE1 and also with the corresponding VipB homologue in a manner
which does not involve the ClpV-N Terminus [Forster et al., 2014]. According to the proposed
secondary structure model and the Nanogold labeling experiments, the VipA N-termini are ac-
cessible at tubule ends in the contracted form, VipA might therefore also act as a recruitment
platform for ClpV in some T6S systems which have evolved an alternative disassembly mode
independent of the N-terminus of VipB [Forster et al., 2014]. Finally, interaction with Hcp in
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the elongated states suggests also a role in T6S complex assembly and in propelling the needle
forward during contraction [Lin et al., 2013, Brunet et al., 2014, Zoued et al., 2014]. This is
also consistent with the secondary structure model of the VipA/B protomer and the modeled
elongated state of the VipA/B tubule, as here, the inner wall of the elongated VipA/B tubule is
also formed by the N-terminal region of VipA.
As described before, there are indications that the N-terminal region of VipA is also in-
volved in the contraction process and the ejection of the needle. Assuming that these mecha-
nisms are indeed conserved in contractile bacteriophages, this suggests that even though there
are no structural similarities to known viral structures, parts of VipA might at least be remotely
structurally related to proteins in other phage-like systems. Apart from the T6S system and
contractile bacteriophages, there is a variety of other phage tail-like structures such as the Pseu-
domonas aeruginosa R-type pyocins [Michel-Briand and Baysse, 2002], the PVC/Afp structures
[Yang et al., 2006, Hurst et al., 2007, Leiman and Shneider, 2012, Rybakova et al., 2013], and
the metamorphosis-associated contractile structure (MAC) of Pseudoalteromonas luteoviolacea
[Shikuma et al., 2014]. As already shown by Aksyuk et al. [2011], Myoviridae tail sheath pro-
teins, albeit having a conserved core, are modified by insertion domains. Also, considering the
tail sheath proteins of related structures, this family of protein complexes demonstrates some
structural plasticity. The tail sheath of R-type pyocins is formed by just one protein with around
40 kDa molecular weight [Nakayama et al., 2000, Gebhart et al., 2012] , while up to three
sheath protein in the range of 40 -50 kDa are identified in PVC/Afp-like structures, and the
putative MAC sheath protein has a molecular weight of 62 kDa. So far, no additional smaller
sheath proteins that coexist in a contractile sheath with gp18-like proteins like in the case of
VipA/B have been reported. However, there are indications that the Afp tail sheath consists of
two different kinds of bigger gp18-like sheath proteins and that the three tail sheath proteins are
functionally distinct [Heymann et al., 2013, Rybakova et al., 2013]. It is therefore likely that
parts of VipA bound to VipB might still resemble their counterparts in other contractile systems,
yet the overall structure of VipA is unique for the T6S system.
Also, VipB is distinct from other gp18-like proteins. Despite the observed structural con-
servations in the core regions of VipB to viral tail sheath proteins, its N-terminal domain is
unique for the Type VI secretion system. Viral tail sheaths protein often present one or two
protease-resistant insertion domains (PRF domains) on the outside of the tubule [Aksyuk et al.,
2011], that putatively function as a protection against extracellular proteases secreted by their
hosts. These PRF domains are replaced by a 4-helix bundle N-terminal domain in VipB that
contains the recognition motif for the ATPase ClpV [Pietrosiuk et al., 2011]. When ClpV binds
via its N-terminal domains to the VipB N-terminus and pulls on the assembly, the tractive force
is directly transferred via helices HB4 and HB5 onto a large β sheet region in the core of VipB
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that might serve as a scaffolding platform. Pulling on it, possibly destabilizes the whole struc-
ture, leading to a partial unfolding of VipB, and to an unhinging of a complete protomer from
the tubule assembly. This would on the one hand explain the presence of intact protomers af-
ter ClpV-mediated disassembly and on the other hand it would be also more efficient as a new
ready-to-fire T6S secretion system is faster available. Experiments testing the specificity of the
ClpV N-terminal domain support this suggestion as only VipB is digested while VipA remains
untouched when incubated with chimeras of the ClpV N-terminal domain and ClpA/P [Pietro-
siuk et al., 2011]. To sum it up, VipA presumably enhances the stability of the T6S tubule while
VipB provides an N-terminal domain dedicated to the recycling of the complex.
With the T6S system being the only known phage-tail like contractile machinery which acts
intracellularly, it is not surprising, that it is greatly adapted towards quick recycling. Indeed, a
phylogenetic analysis of the structurally homologous tail, sheath, and base plate proteins of T6S
systems, phage tail-like structures, R-type pyocins and contractile bacteriophages shows that the
T6S phylogenetic group is more distinct from the latter two, which are more closely related to
each other [Sarris et al., 2014].
4.4 Mechanism for contraction-state specific recycling of the
T6S tubule
Fig. 4.2: Mechanism for T6S tubule recycling. The needle complex formed by Hcp (grey) is
enclosed by the VipA/B tubule. The ClpV recognition motif in HB2 is buried in the tubule wall.
Upon contraction, the VipA/B protomers swing up and outwards ejecting the needle complex.
In the contracted form, the recognition motif is accessible for the ATPase ClpV and the tubule
gets disassembled. Free VipA/B protomers are ready for reassembly into a loaded T6S complex.
The figure is adopted from Kube et al. [2014], please see also section 6.3 Reprints.
The model of the elongated T6S tubule offers an insight into this efficient mechanism for the
recycling of contracted tubules. It has been observed before, that ClpV binds specifically to the
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contracted form of the VipA/B tubule [Basler and Mekalanos, 2012] and it has been suggested
that this is due to a binding site at the N-terminus of VipB which is only accessible in the
contracted state [Kapitein et al., 2013]. However, the exact molecular mechanism has not been
known.
In contrast to the PRF domains of viral tail sheaths that are connected to the core protomer
via flexible loops giving it a S-shape, the VipB N-terminal domain is rigidly connected to its
core by HB4 and HB5 and VipA. Thus, the VipA/B protomer has a rather triangular shape with
the ClpV recognition motif of the VipB-N-terminus located at the tip. As a consequence, even
though the conserved C-terminal and middle regions are in similar positions in the elongated
forms of both systems, the PRF domains are still pointing radially away from the virus tail to
protect it, while the recycling domains of the T6S tubule are buried in the tubule wall. Hence,
ClpV cannot access its binding motif on the elongated tubule and only contracted tubules get
recycled (Fig. 4.2).
4.5 Summary and outlook
This work suggests that the contractile VipA/B tubule shares a similar architecture with other
phage-like contractile structures maintained by structurally conserved VipB core regions. Thus,
its conserved contraction mechanism is likely similar to bacteriophage tail sheaths. The contrac-
tile scaffold formed by structurally conserved parts is functionalized in both systems to adapt
it to its individual purpose. On the one hand, viral tail sheaths are decorated with additional
protease-resistant domains to protect them in the extracellular environment. On the other hand,
the T6S tubule is complemented with a recycling domain on VipB and the putative chaperone
VipA. Hence, the T6S tubule is adapted towards a quick recycling which is more advantageous
considering its intracellular location.
Even though the structure of the VipA/B protomer is resolved up to 6 Å which allows to
trace the peptide chain of VipA and VipB along discernible secondary structure elements, loops
cannot be modeled reliably at this resolution and therefore have been let out. Hence, the obvious
next step is a reconstruction of the tubule resolved to side chain level from a direct detector
dataset and advanced processing techniques as it has been recently demonstrated for other helical
structures [Wu et al., 2014]. A pseudo-atomic model of the full protomer will help to understand
the exact contraction mechanism of the tubule and by analogy also of contractile bacteriophages
and related complexes [Sarris et al., 2014]. However, to accomplish this, also a high-resolution
structure of the elongated tubule is also needed. So far, the elongated T6S tubules could not be
purified as they cannot be directly isolated from wild-type cells and VipA/B only form contracted
tubules when heterologously expressed [Bönemann et al., 2009, Basler et al., 2012]. Here, a
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combination of cryo-ET and helical reconstruction [Bharat et al., 2012] could be applied to get
to sub-nanometer resolution which is sufficient to define conformational changes. Alternatively,
the membrane complex with the T6S tubule bound to it, can be extracted and investigated by
single particle methods as it has been demonstrated for the Type IV secretion system [Low et al.,
2014] or the γ-secretase [Lu et al., 2014]. The contraction mechanism of the T6S tubule can
also be investigated by mutating conserved residues at the interface between neighboring gp18-
like C-terminal domains of VipB. Possible candidates can be drawn by analogy to TssE, which
is predicted to have a very similar fold to the C-terminal domain of VipB [Lossi et al., 2011,
Leiman and Shneider, 2012].
Apart from the T6S system, bacteria employ a variety of phage tail-like systems to interact
with their own and other species in their environment. This makes the most likely conserved
contractile machinery common to all the systems interesting for drug targeting. Alternatively,
the systems are also suitable for a biotechnological use to deliver active components into cells
[Sarris et al., 2014]. It is speculated, that the current problem of antibiotic resistance in many
important pathogens might be circumvented by so called “anti-virulence drugs” [Clatworthy
et al., 2007]. These drugs do not target the viability of the pathogen directly, but the virulence
factors that are employed for infection. As a consequence, the “disarmed” pathogen can be
efficiently exterminated by the immune system of the host. The T6S system is employed by
bacteria to attack competitor species in their environment. For example, it confers a direct
competitive advantage in the plant colonization of A. tumefaciens [Ma et al., 2014] and there
are indications that it also plays role in gut colonization in V. cholerae [Fu et al., 2013]. Initial
efforts have been undertaken to inhibit T6S by impairing the interaction between V. cholerae
VipA and VipB in [Sun et al., 2014]. A future drug might strip V. cholerae of a functional T6S
system. The pathogen can then be outcompeted by the commensal gut flora.
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6 Appendix
6.1 Cross-links detected by mass spectrometry
Table 6.1: Cross-links detected in XL-MS experiments and correlating Cα distances as deduced
from the secondary structure model of the VipA/B protomer.
VipA VipA’ VipB VipB’ interprotomer ? wild-type VipA/VipBΔC209 VipA/VipBΔC366 distance [Å]
K10N K403HB14 x x 29.4
K10N K213HB9 x 29.1
K10N K220HB10 x 29.9
K10N K291HB11 x 19.0
K10N K100HB5 x x 5.2
K16SA1 K223HB10 x 28.8
K16SA1 K213HB9 x 29.3
K16SA1 K291HB11 x 23.9
K16SA1 K75HB4 x 27.2
K16SA1 K100HB5 x 18.8
K16SA1 K10N x x 14.2
K41SA3-HA1 K377HB13 x x 30.0
K41SA3-HA1 K100HB5 x 9.2
K41SA3-HA1 K10N x x 4.5
K59SA4-HA2 K291HB11 x 26.5
K59SA4-HA2 K100HB5 x x 9.7
K59SA4-HA2 K10N x 8.0
K59SA4-HA2 K16SA1 x x 14.9
K59SA4-HA2 K41SA3-HA1 x 7.8
K72HA2-SA5 K59SA4-HA2 x x 23.9
K72HA2-SA5 K41SA3-HA1 x x 29.9
K72HA2-SA5 K10N x x 29.7
K78SA5 K40HB3 x 22.0
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Table 6.1: Cross-links detected in XL-MS experiments and correlating Cα distances as deduced
from the secondary structure model of the VipA/B protomer.
VipA VipA’ VipB VipB’ interprotomer ? wild-type VipA/VipBΔC209 VipA/VipBΔC366 distance [Å]
K78SA5 K100HB5 x 13.3
K78SA5 K41SA3-HA1 x x 13.2
K78SA5 K16SA1 x 18.0
K78SA5 K10N x x 14.0
K78SA5 K59SA4-HA2 x x 15.4
K80SA5-SA6 K41SA3-HA1 x 9.9
K80SA5-SA6 K10N x 10.8
K80SA5-SA6 K72HA2-SA5 x 20.1
K96SA6-HA3 K72HA2-SA5 x 3.9
K114HA3 K78SA5 x 22.1
K115HA3 K41HB3 x x 20.8
K115HA3 K75HB4 x x 12.7
K115HA3 K59SA4-HA2 x x 15.7
K115HA3 K41SA3-HA1 x x 23.4
K115HA3 K16SA1 x 29.9
K115HA3 K10N x x 22.1
K115HA3 K78SA5 x x 20.6
K115HA3 K152HA5 x x 8.6
K115HA3 K80SA5-SA6 x x 18.2
K115HA3 K72HA2-SA5 x x 17.5
K127HA3 K40HB3 x 30.9
K127HA3 K127HA3 x soluble dimer
K127HA3 K59SA4-HA2 x x 21.9
K127HA3 K41SA3-HA1 x x 25.7
K127HA3 K10N x x 21.6
K127HA3 K115HA3 x 18.7
K127HA3 K114HA3 x x 20.2
K127HA3 K78SA5 x 26.1
K127HA3 K80SA5-SA6 x 24.3
K152HA3 K127HA3 x x 17.9
K74HB4 K100HB5 x 26.7
K100HB5 K113SB1 x 16.0
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Table 6.1: Cross-links detected in XL-MS experiments and correlating Cα distances as deduced
from the secondary structure model of the VipA/B protomer.
VipA VipA’ VipB VipB’ interprotomer ? wild-type VipA/VipBΔC209 VipA/VipBΔC366 distance [Å]
K213HB9 K223HB10 x 8.0
K291HB11 K351SB8 x 14.7
K291HB11 K366SB9-HB13 x x 23.7
K291HB11 K377HB13 x x 22.1
K291HB11 K213HB9 x 27.9
K291HB11 K220HB10 x 25.0
K291HB11 K223HB10 x 21.2
K291HB11 K100HB5 x 21.1
K291HB11 K113SB1 x 16.1
K335HB12 K213HB9 x 18.9
6.2 Abbreviations
AAA+ ATPases associated with diverse cellular activities
Akt protein kinase B
ATP adenosine triphosphate
Bam β-barrel assembly machine
CCD charge-coupled device
ClpV caseionlytic protease V (virulent strain)
ddH2O desalted water
dH2O distilled water
DNA deoxyribonucleic acid
DTT dithiothreitol
DotU defect in organelle trafficking U
ECL enhanced chemiluminescence
EDTA ethylenediaminetetraacetic acid
EM electron microscopy
ET electron tomography
FSC Fourier shell correlation
Gac(X) global activator of antibiotic and cyanide production (X)
gp# gene product #
HA human influenza hemagglutinin
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Hcp haemolysin co-regulated protein
HRP horseradish peroxidase
IcmF intracellular multiplication F
Igl(X) intracellular growth locus (X)
IHRSR iterative helical real space refinement
kDa kilo-Dalton
LB lysogeny broth
LC-MS/MS liquid chromatography tandem mass spectrometry
Ni-NTA nickel nitrilotriacetic acid
OmpA outer membrane protein A
PCR polymerase chain reaction
PdpB pathogenecity determinant protein B
PI3K phosphatidylinositol-3-kinase
PpkA polyphosphate kinase A
PppA polyphosphate phosphatase A
retS regulator of exopolysaccharide and type III secretion S
RpoN alternative cofactor for RNA polymerase
rpm revolutions per minute
Rsm(X) regulation of secondary metabolites
SDS sodium dodecyl sulfate
Sec secretory
sRNA small RNA
Tae Type VI secretion amidase effector
Tat twin-arginine translocation
TCA trichloroacetic acid
Tde Type VI secretion DNase effector
Tge Type VI secretion glycoside hydrolase effector
Tle Type VI secretion lipase effector
Vas(X) virulence associated secretion X
VgrG valine-glycine repeat G
VipA ClpV-interacting protein A
VipB ClpV-interacting protein B
XL-MS cross-link mass spectrometry
YFP yellow fluorescent protein
2YT yeast-tryptone
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6.3 Reprints
Figure 3.5 e:
Comparison of class averages and corresponding reprojections: reprinted from Cell
Reports, Vol. 8 , Issue 1, S Kube, N Kapitein, T Zimniak, F Herzog, A Mogk, P
Wendler, Structure of the VipA/B type VI secretion complex suggests a contraction-
state-specific recycling mechanism, p. 20-30, Copyright 2014, with permission
from Elsevier
Figure 3.7:
Analytical tryotic digest of VipA/B tubules: reprinted from Cell Reports, Vol. 8
, Issue 1, S Kube, N Kapitein, T Zimniak, F Herzog, A Mogk, P Wendler, Struc-
ture of the VipA/B type VI secretion complex suggests a contraction-state-specific
recycling mechanism, p. 20-30, Copyright 2014, with permission from Elsevier
Figure 3.8 a, b and parts of c:
Localization of protein termini in VipA/VipB tubules: reprinted from Cell Reports,
Vol. 8 , Issue 1, S Kube, N Kapitein, T Zimniak, F Herzog, A Mogk, P Wendler,
Structure of the VipA/B type VI secretion complex suggests a contraction-state-
specific recycling mechanism, p. 20-30, Copyright 2014, with permission from
Elsevier
Figure 3.9 a:
Overlay of viral tail sheath protein structures: reprinted from Cell Reports, Vol. 8
, Issue 1, S Kube, N Kapitein, T Zimniak, F Herzog, A Mogk, P Wendler, Struc-
ture of the VipA/B type VI secretion complex suggests a contraction-state-specific
recycling mechanism, p. 20-30, Copyright 2014, with permission from Elsevier
Figure 3.10 a:
Diffration pattern of T4 polysheath: reprinted from Journal of Molecular Biology,
Vol. 25, Issue 2, M F Moody, Structure of the sheath of bacteriophage T4 I. Struc-
ture of the contracted sheath and polysheath, p. 167-174, Copyright 1967, with
permission from Elsevier
Figure 3.11:
Predicted structure of the VipB N-terminus: reprinted from Cell Reports, Vol. 8
, Issue 1, S Kube, N Kapitein, T Zimniak, F Herzog, A Mogk, P Wendler, Struc-
ture of the VipA/B type VI secretion complex suggests a contraction-state-specific
recycling mechanism, p. 20-30, Copyright 2014, with permission from Elsevier
Figure 3.12 b:
Topology diagrams of gp18 and VipA/B: reprinted from Cell Reports, Vol. 8 , Issue
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1, S Kube, N Kapitein, T Zimniak, F Herzog, A Mogk, P Wendler, Structure of the
VipA/B type VI secretion complex suggests a contraction-state-specific recycling
mechanism, p. 20-30, Copyright 2014, with permission from Elsevier
Figure 3.13:
Predicted secondary structure profiles of VipA and VipB: reprinted from Cell Re-
ports, Vol. 8 , Issue 1, S Kube, N Kapitein, T Zimniak, F Herzog, A Mogk, P
Wendler, Structure of the VipA/B type VI secretion complex suggests a contraction-
state-specific recycling mechanism, p. 20-30, Copyright 2014, with permission
from Elsevier
Figure 3.14 d:
Inter- and intraprotein cross-links of VipB lysines K291 and K100: reprinted from
Cell Reports, Vol. 8 , Issue 1, S Kube, N Kapitein, T Zimniak, F Herzog, A Mogk, P
Wendler, Structure of the VipA/B type VI secretion complex suggests a contraction-
state-specific recycling mechanism, p. 20-30, Copyright 2014, with permission
from Elsevier
Figure 3.15:
Interprotomer contacts in contracted VipA/B tubules: reprinted from Cell Reports,
Vol. 8 , Issue 1, S Kube, N Kapitein, T Zimniak, F Herzog, A Mogk, P Wendler,
Structure of the VipA/B type VI secretion complex suggests a contraction-state-
specific recycling mechanism, p. 20-30, Copyright 2014, with permission from
Elsevier
Figure 3.16 d-f:
Localization of the interaction site of ClpV on the VipA/B tubule: reprinted from
Cell Reports, Vol. 8 , Issue 1, S Kube, N Kapitein, T Zimniak, F Herzog, A Mogk, P
Wendler, Structure of the VipA/B type VI secretion complex suggests a contraction-
state-specific recycling mechanism, p. 20-30, Copyright 2014, with permission
from Elsevier
Figure 3.17:
Comparison between contracted VipA/B tubules and T4 phage tail sheaths: reprinted
from Cell Reports, Vol. 8 , Issue 1, S Kube, N Kapitein, T Zimniak, F Herzog, A
Mogk, P Wendler, Structure of the VipA/B type VI secretion complex suggests
a contraction-state-specific recycling mechanism, p. 20-30, Copyright 2014, with
permission from Elsevier
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Figure 3.18:
Protomer arrangement in the VipA/B tubule and the T4 sheath: reprinted from Cell
Reports, Vol. 8 , Issue 1, S Kube, N Kapitein, T Zimniak, F Herzog, A Mogk, P
Wendler, Structure of the VipA/B type VI secretion complex suggests a contraction-
state-specific recycling mechanism, p. 20-30, Copyright 2014, with permission
from Elsevier
Figure 4.2:
Mechanism for T6S tubule recycling: reprinted from Cell Reports, Vol. 8 , Issue 1,
S Kube, N Kapitein, T Zimniak, F Herzog, A Mogk, P Wendler, Structure of the
VipA/B type VI secretion complex suggests a contraction-state-specific recycling
mechanism, p. 20-30, Copyright 2014, with permission from Elsevier
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